Quiver News

Company Achieved New Record-High Monthly Deliveries

• 40,397 vehicles were delivered in October 2025, increasing by 92.6% year-over-year
• 241,618 vehicles were delivered year-to-date in 2025, increasing by 41.9% year-over-year
• Cumulative deliveries reached 913,182 as of October 31, 2025
  
  

SHANGHAI, Nov. 01, 2025 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its October 2025 delivery results.

The Company delivered 40,397 vehicles in October 2025, reaching a new monthly record and representing an increase of 92.6% year-over-year. The deliveries consisted of 17,143 vehicles from the Company’s premium smart electric vehicle brand NIO, 17,342 vehicles from the Company’s family-oriented smart electric vehicle brand ONVO, and 5,912 vehicles from the Company’s small smart high-end electric car brand FIREFLY. Cumulative deliveries reached 913,182 as of October 31, 2025.

In October 2025, our smart large-space flagship SUV, the ONVO L90, achieved a new record and sustained its strong growth momentum, with monthly deliveries exceeding 10,000 for three consecutive months since its official launch in late July 2025. With its industry-leading position in the large SUVs segment and extraordinary product competitiveness, the L90 is well-positioned to accelerate the transition of large three-row SUVs toward full electrification.

About NIO Inc.
NIO Inc. is a pioneer and a leading company in the global smart electric vehicle market. Founded in November 2014, NIO aspires to shape a sustainable and brighter future with the mission of “Blue Sky Coming”. NIO envisions itself as a user enterprise where innovative technology meets experience excellence. NIO designs, develops, manufactures and sells smart electric vehicles, driving innovations in next-generation core technologies. NIO distinguishes itself through continuous technological breakthroughs and innovations, exceptional products and services, and a community for shared growth. NIO provides premium smart electric vehicles under the NIO brand, family-oriented smart electric vehicles through the ONVO brand, and small smart high-end electric cars with the FIREFLY brand.

Safe Harbor Statement
This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. NIO may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in announcements, circulars or other publications made on the websites of each of The Stock Exchange of Hong Kong Limited (the “SEHK”) and the Singapore Exchange Securities Trading Limited (the “SGX-ST”), in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about NIO’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: NIO’s strategies; NIO’s future business development, financial condition and results of operations; NIO’s ability to develop and manufacture vehicles of sufficient quality and appeal to customers on schedule and on a large scale; its ability to ensure and expand manufacturing capacities including establishing and maintaining partnerships with third parties; its ability to provide convenient and comprehensive power solutions to its customers; the viability, growth potential and prospects of the battery swapping, BaaS, and NIO Assisted and Intelligent Driving and its subscription services; its ability to improve the technologies or develop alternative technologies in meeting evolving market demand and industry development; NIO’s ability to satisfy the mandated safety standards relating to motor vehicles; its ability to secure supply of raw materials or other components used in its vehicles; its ability to secure sufficient reservations and sales of its vehicles; its ability to control costs associated with its operations; its ability to build its current and future brands; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in NIO’s filings with the SEC and the announcements and filings on the websites of each of the SEHK and SGX-ST. All information provided in this press release is as of the date of this press release, and NIO does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For more information, please visit: http://ir.nio.com

Investor Relations
[email protected]

Media Relations
[email protected]

SHANGHAI and NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- TH International Limited (Nasdaq: THCH), the exclusive master franchisee of Tim Hortons restaurants in China (“Tims China” or the “Company”), today announced that it has entered into a definitive agreement for the issuance of Senior Secured Convertible Notes. Additionally, THCH announced amendments to its existing 2024 unsecured convertible notes.

Transaction Overview

Tims China has entered into agreements providing for the issuance of senior secured convertible notes due September 2029 (“New Secured Notes”) in an aggregate principal amount of approximately US$89.9 million. The Company will use part of the proceeds from the issuance of the New Secured Notes for the repurchase of all outstanding amount due under its variable rate convertible senior notes due 2026.

The New Secured Notes will be convertible directly into newly issued ordinary shares of Tims China at a price equal to 110% of the five-day volume-weighted average share price (“VWAP”) prior to signing. The New Secured Notes are secured by a pledge of 100% of the shares of TH Hong Kong International Limited and an all-asset debenture of Tims China.

Concurrently, Tim Hortons Restaurants International GmbH (“THRI”) and Cartesian Capital Group have agreed to extend the maturity of their 2024 unsecured convertible notes from June 2027 to September 2029, with the conversion price reset to align with the New Secured Notes.

The transaction has been approved by the board of directors of the Company and is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including required regulatory approvals in China.

Additional Information

Further details of these transactions will be provided in a Form 6-K to be filed with the U.S. Securities and Exchange Commission (SEC) and available on the SEC’s website by October 31, 2025.

FORWARD-LOOKING STATEMENTS

Certain statements in this earnings release may be considered forward-looking statements within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, such as the Company’s ability to further grow its business and store network, optimize its cost structure, improve its operational efficiency, and achieve profitable growth. Forward-looking statements are statements that are not historical facts and generally relate to future events or the Company’s future financial or other performance metrics. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “target,” “plan,” “expect,” or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward looking statements. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by the Company and its management, as the case may be, are inherently uncertain and subject to material change. Factors that may cause actual results to differ materially from current expectations include various factors beyond management’s control, including, but not limited to, general economic conditions and other risks, uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in the Company’s Annual Report on Form 20-F, and other filings it makes with the Securities and Exchange Commission. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. Except as required by law, the Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based.

ABOUT TH INTERNATIONAL LIMITED

TH International Limited (Nasdaq: THCH) (“Tims China”) is the parent company of the exclusive master franchisees of Tim Hortons restaurants in mainland China, Hong Kong and Macau. Tims China was founded by Cartesian Capital Group and Tim Hortons Restaurants International GmbH, a subsidiary of Restaurant Brands International Inc. (TSX: QSR) (NYSE: QSR).

The Company’s philosophy is rooted in world-class execution and data-driven decision making and centered around true local relevance, continuous innovation, genuine community, and absolute convenience. For more information, please visit https://www.timschina.com .

INVESTOR AND MEDIA CONTACTS

Investor Relations

Gemma Bakx

[email protected] , or [email protected]

Public and Media Relations

Patty Yu

[email protected]

BEIJING, China, Nov. 01, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 31,767 vehicles in October 2025. As of October 31, 2025, Li Auto’s cumulative deliveries reached 1,462,788.

As Li i6 has accumulated over 70,000 orders since its launch, the Company is taking all necessary steps to facilitate deliveries. Li Auto is also accelerating its global expansion efforts: it opened its first overseas authorized retail store in Uzbekistan in October, offering Li L9, Li L7, and Li L6 to the local market, with two more scheduled to open in Kazakhstan in November. The Company plans to prioritize market expansion in the Central Asia, Middle East, Europe, and Asia-Pacific as it steadily advances its global footprint.

As of October 31, 2025, the Company had 551 retail stores in 157 cities, 554 servicing centers and Li Auto-authorized body and paint shops operating in 225 cities. The Company also had 3,508 super charging stations in operation equipped with 19,417 charging stalls in China.

About Li Auto Inc.

Li Auto Inc. is a leader in China’s new energy vehicle market. The Company designs, develops, manufactures, and sells premium smart electric vehicles. Its mission is: Create a Mobile Home, Create Happiness (创造移动的家,创造幸福的家). Through innovations in product, technology, and business model, the Company provides families with safe, convenient, and comfortable products and services. Li Auto is a pioneer in successfully commercializing extended-range electric vehicles in China. While firmly advancing along this technological route, it builds platforms for battery electric vehicles in parallel. The Company leverages technology to create value for users. It concentrates its in-house development efforts on proprietary range extension systems, innovative electric vehicle technologies, and smart vehicle solutions. The Company started volume production in November 2019. Its current model lineup includes a high-tech flagship family MPV, four Li L series extended-range electric SUVs, and two Li i series battery electric SUVs. The Company will continue to expand its product lineup to target a broader user base.

For more information, please visit: https://ir.lixiang.com .

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “targets,” “likely to,” “challenges,” and similar statements. Li Auto may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”) and The Stock Exchange of Hong Kong Limited (the “HKEX”), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Li Auto’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Li Auto’s strategies, future business development, and financial condition and results of operations; Li Auto’s limited operating history; risks associated with extended-range electric vehicles and high-power charging battery electric vehicles; Li Auto’s ability to develop, manufacture, and deliver vehicles of high quality and appeal to customers; Li Auto’s ability to generate positive cash flow and profits; product defects or any other failure of vehicles to perform as expected; Li Auto’s ability to compete successfully; Li Auto’s ability to build its brand and withstand negative publicity; cancellation of orders for Li Auto’s vehicles; Li Auto’s ability to develop new vehicles; and changes in consumer demand and government incentives, subsidies, or other favorable government policies. Further information regarding these and other risks is included in Li Auto’s filings with the SEC and the HKEX. All information provided in this press release is as of the date of this press release, and Li Auto does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Li Auto Inc.
Investor Relations
Email: [email protected]

Christensen Advisory
Roger Hu
Tel: +86-10-5900-1548
Email: [email protected]

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K9A) (“ Quantum ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that pursuant to the entry into its previously announced at the market offering agreement (the “ ATM Agreement ”) with H.C. Wainwright & Co., LLC (“ Wainwright ”) on February 16, 2024, announces today, the Company at its discretion may offer and sell, from time to time, through Wainwright as sales agent, Class B Subordinate Voting Shares in the capital of the Company (“ Class B Shares ”) having an aggregate offering price of up to US$21,225,000 (the “ ATM Offering ”). A cash commission of 3.0% on the aggregate gross proceeds raised under the ATM Offering will be paid to Wainwright in connection with its services.

Sales of the Class B Shares under the Prospectus will be made in transactions that are deemed to be “at-the-market” offering as defined in Rule 415(a)(4) promulgated under the Securities Act, including sales made directly on or through the Nasdaq Stock Market LLC (“ Nasdaq ”). The Class B Shares will be distributed at the prevailing market prices at the time of each sale. As a result, prices may vary as between purchasers and during the period of distribution. No Class B Shares in the ATM Offering will be sold on the Canadian Securities Exchange (the “ CSE ”) or any other trading market in Canada.

The volume and timing of sales, if any, will be determined at the sole discretion of the Company’s management and in accordance with the terms of the ATM Agreement. If the Company chooses to sell Class B Shares under the ATM Offering, the Company intends to use the net proceeds of the ATM Offering (i) to fund our various clinical studies, trials and development programs, (ii) to fund research and development, and (iii) for general corporate purposes and working capital.

The ATM Offering is being made in the United States pursuant to a registration statement on Form F-3 (File No. 333-276264) filed under the Securities Act of 1933 , as amended (the “ Securities Act ”), with the Securities and Exchange Commission (the “ SEC ”) and declared effective on January 4, 2024 (the “ Registration Statement ”), the base prospectus contained in the Registration Statement (the “ Base Prospectus ”) and the prospectus supplement dated October 31, 2025 (“ Prospectus Supplement ”, together with Base Prospectus, the “ Prospectus ”) filed with the SEC.

You can review our SEC filings, the Registration Statement and Prospectus by accessing the SEC’s internet site at www.sec .g ov or on the Company’s website at www.quantumbiopharma.com, through which you can access our SEC filings.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Quantum BioPharma Inc.

Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly-owned subsidiary, Lucid Psycheceuticals Inc. (“ Lucid ”), Quantum is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) (“ Lucid-MS ”). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum has also licensed UNBUZZD™, a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption for use in the consumer recreational sector, to Celly Nutrition Corp. (“ Celly Nu ”) and is entitled to a royalty on the revenue generated by Celly Nu from sales of products created using the technology rights granted under the licensing agreement. Quantum continues its R&D activities to develop novel formulations for alcohol misuse disorders and continues the development of such treatments for use in the healthcare sector. Quantum maintains a portfolio of strategic investments through its wholly-owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property.

Cautionary Note Regarding Forward-Looking Information

This press release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “plans”, “expects”, “expected”, “scheduled”, “estimates”, “intends”, “anticipates”, “hopes”, “planned” or “believes”, or variations of such words and phrases, or states that certain actions, events or results “may”, “could”, “would”, “might”, “potentially” or “will” be taken, occur or be achieved. More particularly, and without limitation, this press release contains forward-looking statements contained in this press release include statements concerning the future of Quantum and are based on certain assumptions that Quantum has made in respect thereof as of the date of this press release, including those relating to future sales of Class B Shares under the ATM Offering, the offering price therefor and the use of proceeds thereof. Quantum cannot give any assurance that such forward-looking statements will prove to have been correct.

Since forward-looking statements relate to future events and conditions, by their very nature they require making assumptions and involve inherent risks and uncertainties. The Company cautions that although it believes the expectations and material factors and assumptions reflected in these forward-looking statements are reasonable as of the date hereof, there can be no assurance that these expectations, factors and assumptions will prove to be correct and these risks and uncertainties give rise to the possibility that actual results may differ materially from the expectations set out in the forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to a number of known and unknown risks and uncertainties including, but not limited to: the timing and ability to satisfy all applicable listing and regulatory requirements of the CSE and Nasdaq; the fact that the drug development efforts of the Company and Lucid are at a very early stage; the fact that preclinical drug development is uncertain, and the drug product candidates of the Company and Lucid may never advance to clinical trials; the fact that results of preclinical studies and early-stage clinical trials may not be predictive of the results of later stage clinical trials; the uncertain outcome, cost, and timing of product development activities, preclinical studies and clinical trials of the Company and Lucid; the uncertain clinical development process, including the risk that clinical trials may not have an effective design or generate positive results; the potential inability to obtain or maintain regulatory approval of the drug product candidates of the Company and Lucid; the introduction of competing drugs that are safer, more effective or less expensive than, or otherwise superior to, the drug product candidates of the Company and Lucid; the initiation, conduct, and completion of preclinical studies and clinical trials may be delayed, adversely affected or impacted by unforeseen issues; the potential inability to obtain adequate financing; the potential inability to obtain or maintain intellectual property protection for the drug product candidates of the Company and Lucid; the inability of the Company to sell under the ATM Offering or upon the terms outlined herein; the prices at which the Company may sell the Class B Shares in the ATM Offering; and other risks. Accordingly, readers should not place undue reliance on the forward-looking statements contained in this press release, which speak only as of the date of this press release.

Further information regarding factors that may cause actual results to differ materially are included in the Company’s annual and other reports filed from time to time with the Canadian Securities Administrators on SEDAR+ ( www.sedarplus.ca ) and with the SEC on EDGAR ( www.sec.gov ), including the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2024, the Prospectus and Registration Statement, each under the heading “Risk Factors”. This list of risk factors should not be construed as exhaustive. Readers are cautioned that events or circumstances could cause results to differ materially from those predicted, forecasted or projected. The forward-looking statements contained in this document speak only as of the date of this document. Quantum does not undertake any obligation to publicly update or revise any forward-looking statements or information contained herein, except as required by applicable laws. The forward-looking statements contained in this document are expressly qualified by this cautionary statement.

Neither the CSE nor its regulation services provider accept responsibility for the adequacy or accuracy of this release.

Contacts:

Quantum BioPharma Inc.
Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board, Quantum BioPharma Inc.
Email: [email protected]
Telephone: (833) 571-1811

Investor Relations
Investor Relations: [email protected]
General Inquiries: [email protected]

PHILADELPHIA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI (NASDAQ: DVLT) (“Datavault,” “DVLT,” or the “Company”), a leader in data tokenization and management, has noted that Wolfpack Research recently issued a self-serving and malicious short report targeting the Company and its Chief Executive Officer, Nathaniel T. Bradley. The Company strongly condemns this action and issues the following formal statement:

1. The Wolfpack Research Report Contains False and Defamatory Claims Aimed at Manipulating DVLT Stock for Financial Gain

The Wolfpack Research report includes numerous false, misleading, and defamatory statements intended to manipulate Datavault AI’s stock for the financial benefit of short sellers.

These claims lack factual foundation and have caused reputational harm to the Company and its stockholders. Wolfpack Research has openly acknowledged its short position in DVLT shares—demonstrating that its so-called “research” is driven by self-interest rather than truth.

“It’s obvious that these actors are financially benefitting from spreading false information,” said Nathaniel Bradley, Chief Executive Officer of Datavault AI. “We intend to file suit to hold Wolfpack Research accountable for its malicious conduct and to protect the rights of our shareholders.”

Short selling is a recognized market practice; however, intentional market manipulation through false and defamatory statements is not. The Company is evaluating Wolfpack Research’s actions and will pursue all legal remedies available under applicable law.

2. Datavault AI Has Engaged Legal Counsel and Formally Demanded Wolfpack Research Cease and Desist its Tortious Conduct

Datavault AI has retained Paul Hastings LLP and Dickinson Wright PLLC to advise on litigation strategy and regulatory action. The Company is evaluating its legal rights and intends to pursue all available remedies to protect its reputation and the legitimate interests of its stockholders.

Jacob Frenkel, Securities Enforcement Practice Chair at Dickinson Wright PLLC and lead litigation counsel for Datavault AI, stated: “the proper place for such purveyors and backers of ‘short and distort’ content is in a defendant’s chair in a courtroom, and that is exactly where the Company intends to put Wolfpack Research. Such abusive, fraudulent and manipulative practices mislead the market, sow distrust and harm shareholders. Mr. Bradley is committed to acting with the best interest of his Company’s shareholders, which is the precise reason for pursuing legal recourse against such defamatory report-writers. The lawsuit will spell out the false and misleading statements with specificity to the point of being a roadmap for federal enforcement authorities also to put the authors and instigators of the Wolfpack Research report in a defendant’s chair.”

3. Datavault AI Reaffirms the Strength of Its Intellectual Property and Strategic Value

Datavault AI’s value is anchored in its robust intellectual property portfolio, which comprises over 70 U.S. and international patents covering AI-driven data valuation, inaudible audio signal technology, blockchain tokenization frameworks, and enterprise data monetization systems.

“Our strategy is rooted in IP and execution, not speculation,” said Bradley. “The technology we’ve developed is already creating value across industries —from digital identity and healthcare to acoustic data and real-world asset tokenization. That foundation is unshakable.”

Datavault’s IP portfolio provides licensing revenue opportunities and a formidable barrier to entry for competitors. Recent patent grants include those covering carbon-credit tokenization on blockchain, virtual-reality data integration, and AI-driven audio tracking systems.

4. Professional History of Nathaniel T. Bradley

Nathaniel T. Bradley is a prolific American inventor and entrepreneur with more than two decades of experience in mobile marketing, audio processing, AI, and data monetization. He founded AudioEye, Inc. (NASDAQ: AEYE), pioneering digital accessibility technology used worldwide, and later Augme Technologies / Hipcricket, a mobile advertising platform that served Fortune 500 clients. Bradley was recognized as an EY Entrepreneur of the Year Finalist and received the Edison Gold Award for Social Impact.

At Datavault AI, Bradley has led the development of innovations in AI data valuation, blockchain for real-world asset (RWA) tokenization, and AI-powered audio communication through the Company’s ADIO® technology. His reputation for building mission-driven, patent-protected platforms is widely recognized across both technology and capital markets.

5. Recent Successes and Milestones

1. Formed a strategic alliance with NYIAX to enable smart-contract data exchanges.
2. Completed the acquisition of CompuSystems Inc. (CSI) assets, expanding enterprise event data capabilities.
3. Launched the WiSA E Endeavour™ Receiver Module through the Company’s Acoustic Science division.
4. Partnered with Nature’s Miracle Holding Inc. and Harrison Global Holdings Inc. to launch “The X Club” for the global XRP community.
5. Signed a 12-month national media series with New to The Street to enhance investor visibility.
6. Clarified executive vesting disclosures to reinforce corporate governance transparency.
7. Announced the incorporation and preparation of launching four independent data-exchanges – International Elements Exchange Inc., International NIL Exchange Inc., Information Data Exchange Inc., and American Political Exchange Inc., leveraging Datavault AI’s patent portfolio (now exceeding 70 assets) and targeting real-world asset tokenization, NIL rights monetization, corporate data marketplaces and political donation transparency.

About Datavault AI Inc.

Datavault AI™ (Nasdaq: DVLT) is at the forefront of AI-driven data experiences, valuation, and monetization. The company’s cloud-based platform delivers comprehensive solutions with a collaborative emphasis across its Acoustic Science and Data Science Divisions. Datavault AI's Acoustic Science Division features Wisam®, ADIO®, and Sumerian® patented technologies, along with industry-leading foundational spatial and multichannel wireless HD sound transmission technologies, including IP for audio timing, synchronization, and multi-channel interference cancellation. The Data Science Division harnesses high-performance computing to offer solutions for experiential data perception, valuation, and secure monetization. Datavault AI's cloud-based platform serves diverse industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy, and more. The Information Data Exchange® (IDE) enables Digital Twins and licensing of name, image, and likeness (NIL) by securely linking physical real-world objects to immutable metadata, promoting responsible AI with integrity. Datavault AI’s technology suite is fully customizable, featuring AI and Machine Learning (ML) automation, third-party integrations, detailed analytics, marketing automation, and advertising monitoring. The company is headquartered in Beaverton, OR. Learn more at www.dvlt.ai .

Forward-Looking Statements

Certain statements and information included in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will,” “will likely result,” “expected to,” “will continue,” “anticipated,” “estimate,” “projected,” “intend,” “goal,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Forward-looking statements in this press release include, without limitation, those related to the Company’s planned actions against Wolfpack Research, the Company’s prospects and licensing revenue opportunities. Such uncertainties and risks include, but are not limited to, the results of our planned actions against Wolfpack Research, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, dependence on management, demand for products and services of the Company, newly developing technologies, the Company’s ability to compete, regulatory matters, protection of technology, competitive factors, and other factors discussed in the "Risk Factors" section of the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that the Company has filed or may subsequently file with the U.S. Securities and Exchange Commission. Any forward-looking statements contained in this press release are based on the current expectations of the Company’s management team and speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Corporate Communications:

IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[email protected]

Media Contact:

[email protected]

GUADALAJARA, Mexico, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports that, after the passage of Hurricane Melissa through Jamaica, Montego Bay International Airport resumed operations yesterday, October 30, at 4 p.m. (local time) for evacuation flights and humanitarian aid.

At this time, the necessary work is being carried out to restore essential airport infrastructure and services, as well as the assessment of the damage caused to airport facilities and equipment. In accordance with safety protocols and in coordination with local authorities, limited commercial operations are expected to resume on Saturday, November 1 at 7:00 a.m. (local time).

GAP’s priority is to ensure that all airport systems and procedures are fully operational and meet the highest safety standards prior to the full restoration of commercial air operations.

The safety and well-being of our passengers, employees, and business partners remains our highest priority.

GAP will continue to provide timely updates regarding the operations at Montego Bay Airport.

Company Description

Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico’s Pacific region, including the major cities of Guadalajara and Tijuana, the four tourist destinations of Puerto Vallarta, Los Cabos, La Paz and Manzanillo, and six other mid-sized cities: Hermosillo, Guanajuato, Morelia, Aguascalientes, Mexicali, and Los Mochis. In February 2006, GAP’s shares were listed on the New York Stock Exchange under the ticker symbol “PAC” and on the Mexican Stock Exchange under the ticker symbol “GAP”. In April 2015, GAP acquired 100% of Desarrollo de Concessioner Aeroportuarias, S.L., which owns a majority stake in MBJ Airports Limited, a company operating Sangster International Airport in Montego Bay, Jamaica. In October 2018, GAP entered into a concession agreement for the Norman Manley International Airport operation in Kingston, Jamaica, and took control of the operation in October 2019.

In accordance with Section 806 of the Sarbanes-Oxley Act of 2002 and Article 42 of the “Ley del Mercado de Valores”, GAP has implemented a “whistleblower” program, which allows complainants to anonymously and confidentially report suspected activities that involve criminal conduct or violations. The telephone number in Mexico, facilitated by a third party responsible for collecting these complaints, is 800 04 ETICA (38422) or WhatsApp +52 55 6538 5504. The website is www.lineadedenunciagap.com or by email at [email protected] . GAP’s Audit Committee will be notified of all complaints for immediate investigation.

SCOTTSDALE, Ariz., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Caliber (Nasdaq: CWD), a diversified real estate and digital asset management platform, today announced that its Board of Directors has approved a Noteholder Conversion Program (the “Program”) authorizing the ability of holders of certain of Caliber’s unsecured corporate notes to convert such notes into shares of the Company’s Class A common stock. The Program allows such noteholders to convert notes in tranches, each tranche allowing up to an aggregate of $3.0 million of such notes to be converted. Participation in the Program is entirely voluntary, with conversion prices determined according to Nasdaq’s rules for market transactions. The Program is expected to significantly reduce leverage, improve stockholders’ equity, and increase financial flexibility as Caliber advances toward its goal of profitability in 2026.

In connection with this approval, Caliber also announced the completion of 1.9 million conversion of principal balance notes with an average interest rate of 11.1%, representing approximately 561,850 shares issued at an average conversion price of $3.43 per share. This conversion immediately strengthens the Company’s balance sheet and eliminates approximately $211,090 in annual interest expense while improving cash flow..

“By methodically removing high-cost debt from our balance sheet, we are reducing interest expense and freeing up cash flow for growth,” Loeffler added. “This program represents an important next step in fortifying Caliber’s foundation as we execute on our dual strategies: expanding our private equity real estate platform and building one of the largest LINK token treasuries held by a public company.”

DISCLAIMER

This press release does not constitute an offer or solicitation to sell shares or securities in the Company or any related or associated entity.

Any such offer or solicitation will be made solely through investment documentation, in strict accordance with the terms of all applicable securities laws and regulations.

About Caliber (CaliberCos Inc.)

Caliber (Nasdaq: CWD) is an alternative asset manager with over $2.9 billion in Managed Assets and a 16-year track record in private equity real estate investing across hospitality, multi-family, and industrial real estate. In 2025, Caliber became the first U.S. public real estate platform to launch a Digital Asset Treasury strategy anchored in LINK, the token associated with Chainlink. This initiative bridges real and digital asset investing through an equity-funded, disciplined approach that includes staking for yield. Investors can participate via Caliber’s publicly traded equity (Nasdaq: CWD ) and private real estate funds .

Forward-Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on the Company’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the final prospectus related to the Company’s public offering filed with the SEC and other reports filed with the SEC thereafter. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Contacts:
Caliber Investor Relations
Ilya Grozovsky
+1 480-214-1915
[email protected]

NEW YORK, NY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Dynamix Corporation III (the “Company”) announced today the closing of its initial public offering of 20,125,000 units, including 2,625,000 units in connection with the underwriters’ exercise of their option to purchase additional units in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $201,250,000.

The Company’s units began trading on October 30, 2025 on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “DNMXU.” Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “DNMX” and “DNMXW,” respectively.

Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of warrants, $201,250,000 (or $10.00 per unit sold in the public offering) was placed in the Company’s trust account.

Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, acted as the sole book-running manager for the offering. Clear Street LLC acted as co-manager for the offering. The initial public offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from Cohen & Company Capital Markets, 3 Columbus Circle, 24 ^th Floor, New York, NY 10019, Attention: Prospectus Department, Email: [email protected] .

A registration statement relating to the securities became effective on October 29, 2025 in accordance with Section 8(a) of the Securities Act of 1933, as amended. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Dynamix Corporation III

Dynamix Corporation III is a special purpose acquisition company incorporated under the laws of the Cayman Islands for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination in any business or industry, but expects to target opportunities and companies that are in the energy, power and digital infrastructure value chain. The Company is led by the following seasoned investors and industry executives: Andrea “Andrejka” Bernatova, Chief Executive Officer and Chairman, Nader Daylami, Chief Financial Officer, Philip Rajan, Executive Vice President of M&A and Strategy. The Company maintains a corporate website at dynamix3.dynamix-corp.com . Inclusion of the Company’s website address in this press release is an inactive textual reference only.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov . The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Company Contact

Dynamix Corporation III
Andrea Bernatova
1980 Post Oak Blvd., Suite 100, PMB 6373
Houston, TX 77056

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence (the “AI”) technology-driven Platform-as-a-Service (the “PaaS”) company whose technologies have been applied to the human resources and insurance industry verticals, today announced its financial results for 1H fiscal year of 2025.

1H 2025 Financial Highlights

• Our revenue was RMB386.89 million (US$54.01 million) for the six months ended June 30, 2025, compared with RMB605.52 million for the six months ended June 30, 2024, representing a decrease of 36.11%.
• We recorded a gross margin of 33.74% for the six months ended June 30, 2025, representing an increase of 200 bps compared with that of the six months ended June 30, 2024.
• We recorded net income of RMB21.49 million (US$3.0 million) for the six months ended June 30, 2025, compared with RMB53.93 million for the six months ended June 30, 2024.
• Our net income margin decreased to 5.56% for the six months ended June 30, 2025, compared with 8.91% for the six months ended June 30, 2024.

Management Commentary

Howard Lee, Chief Executive Officer of Lucas, said “We continue to position ourselves as a technology company rather than a service company, resulting in improvement of our gross margin in 1H 2025 compared to 1H 2024. The revenue decrease was due to slowdown of the overall Chinese economy, our change of strategy to focus on higher-margin products and our management focus on initiating operations outside China.”

“In order to sustain our technological leads as a technology company, we have continued to invest significantly in research and development. R&D expenses as a percentage of revenue was 11.86% which is still well above industry average. We obtained one additional patent related to core Artificial Intelligence (AI) technology, bringing the total number of granted patents to 20.”

About Lucas GC Limited

With 20 granted U.S. and Chinese patents and over 75 registered software copyrights in the AI, data analytics and blockchain technologies, Lucas GC Limited is an AI technology-driven Platform as a Service (PaaS) company. Lucas’ technologies have been applied to the human resources and insurance industry verticals. For more information, please visit: https://www.lucasgc.com/.

Forward-Looking Statements

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements.” The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the uncertainties related to market conditions. Any forward-looking statements contained in this press release speak only as of the date hereof, and Lucas GC Limited specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise.

For Investor Inquiries and Media Contact:

https://www.lucasgc.com/
[email protected]
T: 818-741-0923

• Diluted earnings per share (“EPS”) of $0.77
• Invested $72 million in water and wastewater utility infrastructure during the nine months ended September 30, 2025, or approximately 77% of the 2025 capital budget
• Declared $0.36 common stock cash dividend, a 5.88% increase
• Executed the asset purchase agreement to acquire Pinewood Acres water utility assets in Delaware

ISELIN, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Middlesex Water Company (“Middlesex” or the “Company”) (NASDAQ: MSEX) today announced financial results for the third quarter ended September 30, 2025.

“We continue to focus on our selective and sustainable growth pillar, and we are pleased to announce the execution of an asset purchase agreement to acquire the water utility asset of Pinewoods Acres in Delaware," said Nadine Leslie, Chair, President and Chief Executive Officer of Middlesex Water Company. "This acquisition aligns with our MWC2030 strategy to bring our high standards of operational excellence, safety, and water quality to a broader customer base.”

Third Quarter 2025 Results

Middlesex reported net income of $14.0 million and diluted EPS of $0.77, compared to net income of $14.3 million and diluted EPS of $0.80 for the same quarter in 2024.

Operating revenues for the quarter ended September 30, 2025, were $54.1 million, a decrease of $1.0 million, compared to $55.1 million for the same quarter last year. The decrease is attributable to lower consumption driven by unfavorable weather partially offset by rate increases and customer growth.

Operating expenses for the quarter ended September 30, 2025, were $36.4 million, a decrease of approximately $1.2 million, compared to $37.6 million for the same quarter last year. The decrease is primarily driven by higher capitalizable costs and lower legal, financial and regulatory costs, partially offset by higher variable production costs from weather-driven lower water quality and higher depreciation.

Year-to-Date Results

Net income for the nine months ended September 30, 2025 was $34.2 million, a $1.3 million decrease when compared to the same period in 2024. Diluted earnings per share were $1.90 and $1.98 for the nine months ended September 30, 2025, and 2024, respectively. The decrease is attributable to the one-time recovery in the first quarter 2024 of previously incurred depreciation, operating and carrying costs of $4.3 million (net of tax) associated with the construction and operation of the water treatment facilities at Middlesex’s Park Avenue water treatment plant and lower consumption driven by unfavorable weather, offset by rate increases and customer growth.

Operating revenues for the nine months ended September 30, 2025, were $147.7 million, an increase of approximately $2.9 million over the same period in 2024. Operating revenues increased $1.8 million in the Middlesex System and $1.4 million in the Tidewater System, largely driven by rate increases and customer growth, partially offset by lower consumption driven by unfavorable weather and a $0.3 million decrease primarily due to lower supplemental contract services revenue in our non-regulated businesses.

Operating expenses for the nine months ended September 30, 2025, increased $2.5 million over the same period in 2024, primarily due to higher variable production costs from weather-driven lower water quality, increased weather-driven main break activity and higher depreciation expense due to higher average utility plant in service and the one-time recovery in 2024 of previously incurred depreciation expense and water treatment operating costs at Middlesex’s Park Avenue water treatment plant.

Selective and Sustainable Growth

Middlesex invested approximately $72 million to upgrade, replace and enhance the resiliency of its water and wastewater utility infrastructure during the nine months ended September 30, 2025, or approximately 77% of its planned 2025 annual investment of $93 million.

In October 2025, Middlesex filed a fourth Distribution System Improvement Charge ("DSIC") rate application that is expected to result in $0.9 million of annual revenues, which is in addition to the existing $2.3 million of annual revenues from previous DSIC filings.

In October 2025, Tidewater Utilities, Inc., a wholly owned subsidiary of Middlesex, filed an application with the Delaware Public Service Commission for approval of the purchase of Pinewood Acres water utility assets for $0.2 million. Pinewood Acres serves approximately 350 customers in Kent County, Delaware.

Dividend Declared, Announced 5.88% Increase

As previously announced on October 24, 2025, the Company’s Board of Directors declared a fourth quarter cash dividend of $0.36 per common share, a 5.88% increase from the $0.34 per share dividend last declared in July 2025. This increase raises the annual dividend rate to $1.44 from $1.36 per share of common stock and marks Middlesex's 53rd consecutive year of dividend increases. The dividend at the new rate is payable December 1, 2025 to shareholders of record as of November 17, 2025. Middlesex has paid cash dividends in varying amounts continually since 1912.

About Middlesex Water Company

Middlesex Water Company (“Middlesex”) is one of the nation’s premier investor-owned water and wastewater utilities. Established in 1897, Middlesex is a trusted provider of life-sustaining services to more than half a million people in New Jersey and Delaware. The company focuses on employee engagement, operational excellence, superior customer experience, investment in infrastructure, and selective and sustainable growth to deliver value to our customers, investors, and the communities we serve.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of U.S. federal securities laws reflecting the current beliefs or expectations of Middlesex Water Company “MSEX” or the “Company” regarding its future performance, its financial condition, its strategic plans and cash flows, its results of operations as well as any other statements that do not directly relate to any historical or current facts. These statements reflect the Company’s current views and information currently available. This information is based on estimates, assumptions, and analysis that the Company believes, as of the date hereof, provide a reasonable basis for the information contained herein. Forward-looking statements can generally be identified by the use of forward-looking words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” “foresees,” or the negative of those words or other comparable terminology. The Company intends that these statements be covered by the safe harbors created under those laws. Actual results, performance or achievements may differ materially from forward-looking statements, and the assumptions on which forward-looking statements are based. There can be no assurance that the information contained herein is reflective of future performance, and investors are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance. Unless otherwise specified, all information contained in this press release speaks only as of the date hereof. The Company undertakes no duty to update or revise the information contained herein, whether as a result of new information, future events or otherwise.

Media Contact:
Brian Hague, Vice President of Communications & Corporate Affairs
[email protected]
(732) 638-7549

Investor Relations Contact:
Jennifer Ketschke, Director of Treasury and Investor Relations
[email protected]
(732) 638-7523

HAMPTON, N.H., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE:UTL) ( unitil.com ) today announced that it completed the purchase of Maine Natural Gas Company (“Maine Natural”) from Avangrid Enterprises, Inc. The Stock Purchase Agreement (the “Agreement”) between Avangrid Enterprises, Inc. and Unitil was first announced on April 1, 2025. All conditions of the Agreement, including the receipt of approvals from the Maine Public Utilities Commission, were materially completed as of the closing date.

Maine Natural commenced operations in 1999 and serves approximately 6,300 residential and commercial natural gas customers in nine communities in the Greater Portland region of Maine, as well as the capital city of Augusta. Maine Natural’s gas system includes approximately 230 miles of distribution mains, providing opportunities for continued customer growth. Maine Natural was estimated to have approximately $69.0 million of rate base as of December 31, 2024. With this acquisition Unitil serves approximately 213,300 customers throughout Maine, New Hampshire, and Massachusetts.

“Maine Natural Gas Company is highly complementary to our existing natural gas distribution operations in Maine,” said Thomas P. Meissner, Jr., Unitil’s Chairman and Chief Executive Officer. “Maine Natural Gas Company brings a dedicated team focused on providing safe, clean, reliable, and affordable energy to customers. We share their dedication to serving communities in Maine by providing responsive, high-quality service through locally managed operations.”

The purchase price was $86.0 million, plus approximately $7.1 million for estimated working capital, including cash on hand and certain regulatory assets.  Unitil funded $86.0 million of the purchase price through a term loan from Scotiabank with the balance coming from its existing sources of funds.

Unitil was advised in this transaction by Scotiabank, and by the law firm of Dentons.

About Unitil Corporation

Unitil Corporation provides energy for life by safely and reliably delivering electricity and natural gas in New England. We are committed to the communities we serve and to developing people, business practices, and technologies that lead to the delivery of dependable, more efficient energy. Unitil Corporation is a public utility holding company with operations in Maine, New Hampshire and Massachusetts. Unitil’s operating utilities, including Maine Natural, serve approximately 109,400 electric customers and 103,900 natural gas customers. For more information about our people, technologies, and community involvement please visit unitil.com .

Forward Looking Statements

This press release may contain forward-looking statements. All statements, other than statements of historical fact, included in this press release are forward-looking statements. Forward-looking statements include declarations regarding Unitil’s beliefs and current expectations. These forward-looking statements are subject to the inherent risks and uncertainties in predicting future results and conditions that could cause the actual results to differ materially from those projected in these forward-looking statements. Some, but not all, of the risks and uncertainties include the following: hazards and operating risks relating to the Company’s electric and natural gas distribution activities; fluctuations in the supply of, the demand for, and the prices of, energy commodities and transmission and transportation capacity and Unitil’s ability to recover energy commodity costs in its rates; catastrophic events; cyber-attacks, acts of terrorism, acts of war, severe weather, a solar event, an electromagnetic event, a natural disaster, the age and condition of information technology assets, human error, or other factors could disrupt the Company’s operations; outsourcing of services to third parties could expose the Company to substandard quality of service delivery or substandard deliverables; unforeseen or changing circumstances, which could adversely affect the reduction of company-wide direct greenhouse gas emissions; Unitil’s regulatory environment (including regulations relating to climate change, greenhouse gas emissions and other environmental matters); general economic conditions; the Company’s ability to obtain debt or equity financing on acceptable terms; increases in interest rates; the Company's payment of dividends in the future; declines in capital market valuations; the Company's ability to consummate acquisitions or other strategic transactions; impairment of the Company's assets; restrictive covenants contained in the terms of the Company’s and its subsidiaries’ indebtedness; customers’ preferred energy sources; severe storms and Unitil’s ability to recover storm costs in its rates; variations in weather; long-term global climate change; macroeconomic events, including the imposition of tariffs; employee workforce factors, including the ability to attract and retain key personnel; Unitil’s ability to retain its existing customers and attract new customers; increased competition; and other presently unknown or unforeseen factors. Other risks are detailed in Unitil's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date they are made. Unitil undertakes no obligation, and does not intend, to update these forward-looking statements except as required by law.

For more information please contact:

Christopher Goulding – Investor Relations
Phone: 603-773-6466
Email: [email protected]

Amanda Vicinanzo – External Affairs
Phone: 603-773-6474
Email: [email protected]

GIG HARBOR, Wash., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Heritage Distilling Holding Company Inc. d/b/a IP Strategy (Nasdaq: IPST) (the “Company”), the first company to adopt a treasury reserve policy centered on the $IP token, today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock. The reverse stock split is expected to become effective at 12:01 a.m. on November 5, 2025 , and the Company’s common stock is expected to begin trading on the Nasdaq Capital Market on a split-adjusted basis when the market opens on November 5, 2025 , under its existing ticker symbol, “IPST.” The new CUSIP number will be 42727R 203.

Upon effectiveness, every 20 shares of the Company’s issued and outstanding common stock will be automatically combined into one share of common stock. The reverse stock split will not affect the number of authorized shares of common stock or preferred stock, the par value of the common stock, or the rights of stockholders, except for adjustments resulting from the treatment of fractional shares. No fractional shares will be issued; stockholders who would otherwise receive a fractional share will be entitled to a cash payment in lieu thereof equal to the product of the closing sale price of the common stock on the Nasdaq Capital Market on November 4, 2025, and the amount of the fractional share. The reverse stock split will apply to the shares of common stock issuable upon the exercise of outstanding warrants and stock options, with proportionate adjustments to be made to the exercise prices thereof.

The reverse stock split is intended to bring the Company into compliance with Nasdaq’s minimum bid price requirement and to improve the marketability and liquidity of IP Strategy’s common stock. At the Special Meeting of Stockholders held on September 18, 2025, the Company’s stockholders authorized the Company’s board of directors to effect a reverse stock split with a ratio ranging from 1-for-5 up to 1-for-20.

Stockholders holding shares through a broker, bank, or other nominee will have their positions automatically adjusted to reflect the reverse stock split and will not need to take any action. Registered stockholders holding shares in book-entry form will have their accounts automatically updated as well.

About IP Strategy

IP Strategy (Nasdaq: IPST) is the first Nasdaq-listed company to hold $IP tokens as a primary reserve asset and operate a validator for the Story Protocol. The Company provides public market investors broad exposure to the $80 trillion programmable intellectual property economy in a regulated equity format. IP Strategy’s treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.

Heritage Distilling Holding Company, Inc. is the registered corporate name of IP Strategy.
More information can be found at www.ipstrategy.co .

About Story / $IP Token

Story is the AI-native blockchain network powering the $IP token and making intellectual property programmable, traceable, and monetizable in real time. Backed by $136 million from a16z crypto, Polychain Capital, and Samsung Ventures, Story launched its mainnet in February 2025 and has rapidly become a leading infrastructure for tokenized intellectual property. Story allows creators and enterprises to turn media, data, and AI-generated content into legally enforceable digital assets with embedded rights, enabling automated licensing and new markets for intellectual property across AI and entertainment.

Forward-Looking Statements

This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements include, but are not limited to, the timing and impact of the reverse stock split, the marketability and liquidity of the Company’s common stock and the Company’s ability to regain compliance with Nasdaq’s continued listing standards.

Any forward-looking statements in this press release are based on IP Strategy’s current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the timing and effectiveness of the reverse stock split, that a reverse stock split, if completed, may not result in the sustained price increase needed to regain Nasdaq compliance, the Company's ability to regain compliance with Nasdaq’s continued listing standards, volatility of the Company’s common stock and any correlation between the Company’s stock price and the price of $IP tokens. These and other risks concerning IP Strategy are described in additional detail in its registration statement on Form S-1 initially filed with the SEC on August 26, 2025, as amended by Amendment No. 1 filed on October 16, 2025, its latest annual report on Form 10-K, subsequent quarterly reports on Form 10-Q and annual reports on Form 10-K, and any other subsequent filings with the SEC. IP Strategy explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

Investor Contact

(800) 595-3550
[email protected]

Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients

Preparing to submit Investigational New Drug applications for the treatment of psoriasis with CYPS317 and the treatment of multiple sclerosis with CYMS101

HOUSTON, Oct. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced third quarter 2025 financial results and provided a corporate update.

Recent Highlights

• Announced positive IND-enabling updates from the psoriasis research program demonstrating the potential of human dermal fibroblast spheroids as a novel therapeutic approach for chronic-relapse psoriasis.
• Advanced the Bone Marrow Organoid platform, offering promising new treatment options for hematopoietic cancers and age-related immune decline.
• Filed patent application with the United States Patent and Trademark Office covering methods of generating multipotent cells from fibroblasts found in donor tissue for clinical applications.
• Published a leadership-authored article in the Opinion Pages presenting the scientific case for fibroblast cells' therapeutic advantages compared to stem cell therapies.
• Presented recent updates on fibroblast-based therapies for chronic disease treatments at the Cell & Gene Meeting on the Mesa, H.C. Wainwright 27th Annual Global Investment Conference, and the 2025 ThinkEquity Conference.
• Implemented cost efficient measures to reduce operating expenses and focus resources on near-term pipeline priorities.

Upcoming Milestones

• Complete manufacturing training runs for CYWC628 and confirm sterility of the manufacturing process by the end of 2025.
• Complete the manufacturing of CYWC628 in accordance with FDA Good Manufacturing Practices (cGMP).
• Initiate Phase 1/2 clinical trial in Australia evaluating fibroblast-based spheroids product candidate, CYWC628, in diabetic foot ulcers (DFU) patients in the first quarter of 2026.
• Complete Phase 1/2 clinical trial in Australia in DFU patients in the third quarter of 2026.
• Complete pre-clinical IND-enabling studies for the treatment of psoriasis with CYPS317, FibroBiologics’ fibroblast spheroid product candidate, and submit IND.
• Complete pre-clinical IND-enabling studies for the treatment of multiple sclerosis with CYMS101, FibroBiologics’ fibroblast spheroid product candidate, and submit IND.

“This quarter brought our strategy into greater focus,” said Pete O’Heeron, Founder and Chief Executive Officer of FibroBiologics. “We are efficiently moving our most advanced product candidates towards the clinic while laying the groundwork to demonstrate that fibroblasts can be a scalable platform and not simply a single-asset bet. Our fibroblast platform will enter the clinic with our Phase 1/2 trial in diabetic foot ulcer patients in the first quarter next year, as we execute against defined milestones to validate its biology, the technology, and the regulatory and commercial path forward.”

Financial Highlights for the Nine Months Ended September 30, 2025

• Research and development expenses were approximately $6.6 million for the nine months ended September 30, 2025, compared to approximately $3.1 million for the same period in 2024. The increase was primarily due to increased contract research costs of $0.4 million for cell manufacturing activities; increased CRO costs of $2.1 million to prepare for a clinical trial; increased lab facilities expense of $0.2 million for lab rent; increased personnel related expenses of $0.3 million due to hiring additional research scientists; and increased research materials and supplies expenses of $0.5 million due to increased laboratory personnel and preclinical studies.
• General and administrative expenses were approximately $7.4 million for the nine months ended September 30, 2025, compared to approximately $6.9 million for the same period in 2024. The increase was primarily due to increased expenses of $0.7 million for added personnel in 2025, which includes stock-based compensation expense; increased professional fees of $0.2 million for accounting, legal and marketing expenses; increased travel expenses of $0.1 million; and decreased Direct Listing related expenses of $0.4 million.
• For the nine months ended September 30, 2025, FibroBiologics reported a net loss of approximately $15.4 million compared to a net loss of approximately $8.1 million for the same period in 2024. The net loss for the nine months ended September 30, 2025, was primarily due to the increase in both research and development expenses and general and administrative expenses discussed above.
• Cash and cash equivalents totaled approximately $4.9 million at September 30, 2025.

For more information, please visit FibroBiologics’ website or email FibroBiologics at [email protected] .

Cautionary Statement Regarding Forward-Looking Statements

This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the status, timing and plans for manufacturing FibroBiologics’ product candidates, the potential clinical benefits of fibroblasts and fibroblast-derived materials, plans for, and the anticipated timing of the initiation and completion of, FibroBiologics’ current and future preclinical studies, clinical trials, and research and development programs, the robustness, progress, and momentum of FibroBiologics’ research and development program, the potential of product candidates as scalable platform technologies, the potential indications for FibroBiologics’ programs, and plans for, and the timing of, regulatory filings. These forward-looking statements are based on FibroBiologics' management's current expectations, estimates, projections, and beliefs, as well as a number of assumptions concerning future events. When used in this communication, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside FibroBiologics' management's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including those set forth under the caption "Risk Factors" and elsewhere in FibroBiologics' annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the SEC and any subsequent public filings. Copies are available on the SEC's website, www.sec.gov. These risks, uncertainties, assumptions and other important factors include, but are not limited to: (a) risks related to FibroBiologics' liquidity and its ability to maintain capital resources sufficient to conduct its business; (b) expectations regarding the initiation, progress and expected results of FibroBiologics’ R&D efforts and preclinical studies; (c) the unpredictable relationship between R&D and preclinical results and clinical study results; (d) the ability of FibroBiologics to successfully prosecute its patent applications; (e) FibroBiologics’ ability to manufacture its product candidates; and (f) FibroBiologics’ ability to conduct clinical trials. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FibroBiologics assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. FibroBiologics gives no assurance that it will achieve its expectations.

About FibroBiologics

Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit www.FibroBiologics.com .

General Inquiries:
[email protected]

Investor Relations:
Nic Johnson
Russo Partners
(212) 845-4242
[email protected]

Media Contact:
Liz Phillips
Russo Partners
(347) 956-7697
[email protected]

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE:BKKT) announced today that David Clifton, an ICE executive and a founding member of Bakkt’s Board, has stepped down from his position on the Company’s Board, following years of service in establishing and guiding the Company’s foundation.

Jeff Sprecher, Founder, Chair and CEO of ICE, commented, “ICE’s support for Bakkt has never been stronger. Under Akshay Naheta’s leadership and with Bakkt’s proven regulatory and technological foundation, we believe Bakkt is well-positioned for long-term success.”

In addition to his role on the Board, Mr. Clifton also served as interim CEO of the Company in 2020, prior to its initial public offering. Under the terms of the IPO, ICE retained the right to designate one member of the Company’s Board for two years after the IPO, and designated Mr. Clifton for that position; however, Mr. Clifton served an additional two years to help build the business. The Company believes that the timing of this transition is appropriate: ICE remains a major shareholder fully aligned with Bakkt’s success, while Bakkt continues with an increasingly independent board and a new leadership team.

Akshay Naheta, Bakkt’s CEO, stated, “We are grateful to David Clifton for his instrumental role in Bakkt’s journey from inception. We also value ICE’s enduring support as we approach the completion of our transformation this year and prepare to enter Bakkt’s next phase of growth starting in 2026.”

Mr. Clifton said, “Bakkt was built to operate with the rigor and independence expected of a public company, and this transition reflects that maturity. I’m proud to have been a part of a business that continues to evolve under Akshay’s leadership and a strong, independent board.”

About ICE
Intercontinental Exchange, Inc. (NYSE: ICE) is a Fortune 500 company that designs, builds, and operates digital networks that connect people to opportunity. We provide financial technology and data services across major asset classes helping our customers access mission-critical workflow tools that increase transparency and efficiency. ICE’s futures, equity, and options exchanges -- including the New York Stock Exchange -- and clearing houses help people invest, raise capital and manage risk. We offer some of the world’s largest markets to trade and clear energy and environmental products. Our fixed income, data services and execution capabilities provide information, analytics and platforms that help our customers streamline processes and capitalize on opportunities. At ICE Mortgage Technology , we are transforming U.S. housing finance, from initial consumer engagement through loan production, closing, registration and the long-term servicing relationship. Together, ICE transforms, streamlines, and automates industries to connect our customers to opportunity.

Trademarks of ICE and/or its affiliates include Intercontinental Exchange, ICE, ICE block design, NYSE and New York Stock Exchange. Information regarding additional trademarks and intellectual property rights of Intercontinental Exchange, Inc. and/or its affiliates is located here . Key Information Documents for certain products covered by the EU Packaged Retail and Insurance-based Investment Products Regulation can be accessed on the relevant exchange website under the heading “Key Information Documents (KIDS).”

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Statements in this press release regarding ICE's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ICE's Securities and Exchange Commission (SEC) filings, including, but not limited to, the risk factors in ICE's Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on February 6, 2025.

About Bakkt
Founded in 2018, Bakkt is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy — spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. With the scale, security, and regulatory compliance demanded by global institutions, Bakkt is positioned at the center of a generational transformation in what money is, how it moves, and how markets operate.

Bakkt is headquartered in New York, NY. For more information, visit: https://www.bakkt.com/ |
X @Bakkt | LinkedIn

For investor and media inquiries, please contact:

Investor Relations
Yujia Zhai
Orange Group
[email protected]

Media
Luna PR
[email protected]
[email protected]

Source: Bakkt Holdings, Inc.

Cautionary Note Regarding Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities and Exchange Act of 1934, as amended. Forward-looking statements can be identified by words such as “will,” “likely,” “expect,” “continue,” “anticipate,” “estimate,” “believe,” “intend,” “plan,” “projection,” “outlook,” “grow,” “progress,” “potential” or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements. However, the absence of these words does not mean that the statements are not forward-looking. Such forward-looking statements are based upon the current beliefs and expectations of the Company’s management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and beyond the Company’s control.

Actual results and the timing of events may differ materially from the results anticipated in such forward-looking statements as a result of the following factors, among others: the Company’s ability to grow and manage growth profitably; whether the Company will be able to successfully integrate its operations with those of Distributed Technologies Research Ltd. (“DTR”), including its infrastructure, and achieve the expected benefits therefrom; the regulatory environment for crypto currencies and digital stablecoin payments; changes in the Company’s business strategy, including its adoption of a digital asset treasury strategy; the price of digital assets; risks associated with owning digital assets, including price volatility, limited liquidity and trading volumes, relative anonymity, potential widespread susceptibility to market abuse and manipulation, compliance and internal control failures at exchanges and other risks inherent in its entirely electronic, virtual, form and decentralized network; the fluctuation of the Company’s operating results, including because the Company may be required to account for its digital assets at fair value; the Company’s ability to time the price of its purchase of digital assets pursuant to its strategy; the impact of the market value of digital assets on the Company’s ability to satisfy its financial obligations, including any debt financings; unrealized fair value gains on its digital asset holdings subjecting the Company to the corporate alternative minimum tax; legal, commercial, regulatory and technical uncertainty regarding digital assets and enhanced regulatory oversight of companies holding digital assets including the possibility that regulators reclassify any digital assets the Company holds as a security causing the Company to be in violation of securities laws and be classified as an “investment company” under the Investment Company Act of 1940; competition by other Bitcoin treasury companies and the availability of spot-traded products for Bitcoin; enhanced regulatory oversight as a result of the Company’s treasury strategy; the possibility of experiencing greater fraud, security failures or operational problems on digital asset trading venues compared to trading venues for more established asset classes, and any malfunction, breakdown or abandonment of the underlying blockchain protocols, or other technological difficulties, may prevent access to or use of such digital assets; the concentration of the Company’s expected digital asset holdings relative to non-digital assets; the inability to use the Company’s digital asset holdings as a source of liquidity to the same extent as cash and cash equivalents, due to, for example, risks associated with digital assets and other risks inherent to its entirely electronic, virtual form and decentralized network; the Company or a third-party service provider experiencing a security breach or cyber-attack where unauthorized parties obtain access to its digital assets; the loss of access to or theft or data loss of the Company’s digital assets, which could be unrecoverable due to the immutable nature of blockchain transactions; if the Company elects to hold its digital assets through a third-party custodian, the loss of direct control over its digital assets and dependence on the custodian’s security practices and operational integrity which may lead to the loss of its digital assets as a result of the insolvency of the custodian, theft by employees or insiders of the custodian or if the custodian’s security measures are comprised, including as a result of a cyber-attack; the Company not being subject to the legal and regulatory protections applicable to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisers; the non-performance, breach of contract or other violations by counterparties assisting the Company in effecting its treasury strategy; the Company’s future capital requirements and sources and uses of cash, including funds to satisfy its liquidity needs; changes in the market in which the Company competes, including with respect to its competitive landscape, technology evolution or changes in applicable laws or regulations; changes in the markets that the Company targets; volatility and disruptions in the crypto, digital payments and stablecoin markets that subject the Company to additional risks, including the risk that banks may not provide banking services to the Company and market sentiments regarding crypto currencies, digital payments and stablecoins; the possibility that the Company may be adversely affected by other macroeconomic, geopolitical, business, and/or competitive factors; the Company’s ability to launch new services and products, including with its expected commercial partners, or to profitably expand into new markets and services; the Company’s ability to execute its growth strategies, including identifying and executing acquisitions and divestitures and the Company’s initiatives to add new clients; the Company’s ability to reach definitive agreements with its expected commercial counterparties; the Company’s ability to successfully complete a strategic transaction of the Loyalty business; the Company’s failure to comply with extensive government regulations, oversight, licensure and appraisals; uncertain and evolving regulatory regime governing blockchain technologies, stablecoins, digital payments and crypto; the Company’s ability to establish and maintain effective internal controls and procedures; the exposure to any liability, protracted and costly litigation or reputational damage relating to the Company’s data security; the impact of any goodwill or other intangible assets impairments on the Company’s operating results; the Company’s ability to maintain the listing of its securities on the New York Stock Exchange; and other risks and uncertainties indicated in the Company’s filings with the SEC, including its most recent Annual Report on Form 10-K for the year ended December 31, 2024 and its most recent quarterly report on Form 10-Q for the quarter ended June 30, 2025, and the risks regarding the Company’s adoption of its Treasury Strategy set forth on in Exhibit 99.1 to its Current Report on Form 8-K, dated as of the date hereof.

You are cautioned not to place undue reliance on such forward-looking statements. Such forward-looking statements relate only to events as of the date on which such statements are made and are based on information available to us as of the date of this release.

Singapore, Oct. 31, 2025 (GLOBE NEWSWIRE) -- As previously reported, on April 25, 2025, Springview Holdings Ltd (Nasdaq: SPHL) (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) regarding the Company’s failure to comply with Nasdaq Continued Listing Rule 5550(a)(2) (the “Rule”), which requires listed securities to maintain a minimum bid price of $1.00 per share. A failure to comply with Rule 5550(a)(2) exists when listed securities fail to maintain a closing bid price of at least $1.00 per share for 30 consecutive business days. Based on the closing bid price for the last 30 consecutive business days prior to April 25, 2025, the Company failed to meet the aforesaid requirement. Therefore, in accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until October 22, 2025, to regain compliance with the Rule.

On October 24, 2025, the Company received a letter from the Listing Qualifications Department of the Nasdaq regarding the Company’s failure to regain compliance with Listing Rule 5550(a)(2), which resulted in a Staff Delisting Determination under Rule 5810(3)(A)(ii). Under the Staff Delisting Determination, the trading of the Company’s Class A ordinary shares will be suspended at the opening of business on November 4, 2025.

The Company has appealed Staff’s determination to a Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. The Company has been informed that hearings are typically scheduled to occur approximately 30-45 days after the date of the hearing request. The request for a hearing must be received by the Nasdaq Hearings Department no later than 4:00 p.m. Eastern Time on October 31, 2025. Although the Company will use all reasonable efforts to regain compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq listing criteria.

About Springview Holdings Ltd

Springview Holdings Ltd (Nasdaq: SPHL) designs and constructs residential and commercial buildings in Singapore, with an operating history dating back to 2002. Springview’s projects cover four main types of work: new construction, reconstruction, additions and alterations, and other general contracting services. With a skilled team of in-house experts, the Company provides a one stop solution that fosters strong customer relationships, offering a comprehensive range of services such as design, construction, furniture customization and project management. The Company also offers post-project services, including defect repairs and maintenance, that further enhances its customer engagement and future project opportunities. For more information, please visit the Company’s website: https://ir.springviewggl.com/ .

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this announcement are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. All statements other than statements of historical facts included in this announcement are forward-looking statements. Forward-looking statements include, but are not limited to, express or implied statements regarding expectations, hopes, beliefs, intentions or strategies of the Company regarding the future including, without limitation, express or implied statements regarding: the expected completion of the Private Placement, the potential full exercise of the warrant and the additional proceeds therefrom. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. Forward-looking statements are based on current expectations and assumptions that, while considered reasonable are inherently uncertain. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties.  The Company’s actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include the risks and uncertainties described in the Company’s annual report on Form 20-F for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the “Commission”) on April 28, 2025, and the Company’s other filings with the Commission. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

For more information, please contact:
Springview Holdings Ltd
Investor Relations Department
Email: [email protected]

BOSTON, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on October 15, 2025, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 113,478 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 24,319 shares of Vor Bio’s common stock to 20 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).

The stock options have a ten-year term, and the exercise price is $30.22 per share, which is equal to the closing price of Vor Bio’s common stock on the grant date of the stock options and RSUs. The options will vest over a four-year period, with 25% of the shares vesting after 12 months and the remaining shares vesting monthly over the following 36 months, subject to the employees’ continued employment with Vor Bio on such vesting dates. The RSUs will vest over a four-year period, with 25% of the shares vesting after 12 months and the remaining shares vesting quarterly over the following 36 months, subject to the employees’ continued employment with Vor Bio on such vesting dates. The options and RSUs are subject to the terms and conditions of the Inducement Plan and the terms and conditions of an award agreement covering the grants.

About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com .

Media & Investor Contacts:
Carl Mauch
[email protected]

Sarah Spencer
[email protected]

AYER, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- AMSC ^® (NASDAQ: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™ and protect and expand the capability of our Navy’s fleet, announced today that it plans to release its second quarter fiscal year 2025 financial results after the market close on Wednesday, November 5, 2025. In conjunction with this announcement, AMSC management will participate in a conference call with investors and covering analysts beginning at 10:00 a.m. Eastern Time on Thursday, November 6, 2025. On this call, management will discuss the Company’s recent accomplishments, financial results, and business outlook.

Those who wish to listen to the live or archived conference call webcast should visit the “Investors” section of the Company’s website at https://ir.amsc.com. The live call can be accessed 15 minutes prior to the scheduled start time by dialing 1-844-481-2802 or 1-412-317-0675 and asking to join the AMSC call.

A replay of the call may be accessed 2 hours following the call by dialing 1-877-344-7529 and using conference passcode 7624698.

About AMSC (Nasdaq: AMSC)
AMSC generates the ideas, technologies and solutions that meet the world’s demand for smarter, cleaner … better energy™. Through its Gridtec™ Solutions, AMSC provides the engineering planning services and advanced grid systems that optimize network reliability, efficiency and performance. Through its Marinetec™ Solutions, AMSC provides ship protection systems and is developing propulsion and power management solutions designed to help fleets increase system efficiencies, enhance power quality and boost operational safety. Through its Windtec™ Solutions, AMSC provides wind turbine electronic controls and systems, designs and engineering services that reduce the cost of wind energy. The Company’s solutions are enhancing the performance and reliability of power networks, increasing the operational safety of navy fleets, and powering gigawatts of renewable energy globally. Founded in 1987, AMSC is headquartered near Boston, Massachusetts with operations in Asia, Australia, Europe and North America. For more information, please visit www.amsc.com.

©2025 AMSC. AMSC, American Superconductor, NEPSI, Neeltran, NWL, D-VAR, D-VAR VVO, Amperium, Gridtec, Marinetec, Windtec, Orchestrate the Rhythm and Harmony of Power on the Grid and Smarter, Cleaner … Better Energy are trademarks or registered trademarks of American Superconductor Corporation. All other brand names, product names, trademarks, or service marks belong to their respective holders.

Hong Kong, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Global Engine Group Holding Limited (the “Company”), a Hong Kong-headquartered integrated solutions provider in information communication technologies (“ICT”), today announced that it has received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”), dated October 27, 2025, stating that the Company is not in compliance with the requirement to maintain a minimum bid price of $1 per share as set forth under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) for continued listing on The Nasdaq Capital Market.

Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based upon the closing bid price of the Company’s Class A ordinary shares (the “Shares”) for the last 30 consecutive business days, the Company no longer satisfies this requirement.

The Notice indicated that the Company has 180 calendar days, or until April 27, 2026 (the “Compliance Period”), to regain compliance with the Minimum Bid Price Rule. To regain compliance with the Minimum Bid Price Rule, the closing bid price of the Company’s Shares must be at least $1.00 per share for a minimum of 10 consecutive business days at any time prior to the expiration of the Compliance Period.

The Notice has no immediate effect on the listing of the Company’s Shares, which will continue to trade on the Nasdaq Capital Market under the symbol “GLE.”

The Company is monitoring the closing bid price of the Shares and evaluating options to regain compliance with the Minimum Bid Price Rule, including by effecting a reverse stock split, if necessary. However, there can be no assurance that the Company will be able to regain or maintain compliance with the Minimum Bid Price Rule.

About Global Engine Group Holding Limited

Global Engine Group Holding Limited is an integrated solutions provider that operates via wholly-owned subsidiaries incorporated in Hong Kong to deliver (i) ICT solution services which include the cloud platform deployment, IT system design and configuration, maintenance, data center colocation and cloud services; (ii) technical services which include the technical development, support, and outsourcing services for data center and cloud computing infrastructure, mobility and fixed network communications, as well as IoT projects; and (iii) project management services which enhances productivity and collaboration management and enables successful implementations and adoption of solutions for customers, to drive business outcomes and innovation for its customers. The Company’s target customer groups include: (i) small to medium-sized telecom operators and ICT service providers seeking expansion in Hong Kong and the South East Asian market; (ii) data center and cloud computing services providers; and (iii) Internet-of-things (“IoT”) solutions providers. For more information, please visit: www.globalengine.com.hk ; ir.globalengine.com.hk/ .

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These forward-looking statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov . The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:
Investor Relations
WFS Investor Relations Inc.
Janice Wang, Managing Partner
Email: [email protected]
Phone: +1 628 283 9214

CHARLOTTE, N.C., Oct. 31, 2025 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that Harold Bevis, President and Chief Executive Officer will be presenting at the Gabelli Funds 49 ^th Annual Automotive Symposium on November 3, 2025 in Las Vegas.

The presentation will begin at 4:30 p.m. PT (7:30 p.m. ET) on Monday, November 3, 2024. Investors interested in accessing the Company’s presentation may register to access the live event here . All registrants will receive a link to the event upon registration. A link to the presentation and associated materials can also be accessed through the investor section of the Company’s website at www.nninc.com .

About NN, Inc.
NN, Inc., a global diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has facilities in North America, Europe, South America, and Asia. For more information about the company and its products, please visit www.nninc.com .

Investor Relations:
Joe Caminiti or Stephen Poe, Investors
[email protected]
312-445-2870

Lima, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Lima, PERU, October 31 ^st , 2025 – Credicorp Ltd. announces to its shareholders and the market that its 3Q25 Earnings Release will be published on Thursday, November 13 ^th , 2025, after market close.

Credicorp’s webcast and conference call to discuss these results will be held on Friday, November 14 ^th , 2025, at 9:30 a.m. Lima, Peru time and 9:30 a.m. Eastern Time.

The call will be hosted by the following Credicorp executives

• Gianfranco Ferrari, Chief Executive Officer
• Alejandro Perez Reyes, Chief Financial Officer
• Francesca Raffo, Chief Innovation Officer
• Cesar Rios, Chief Risk Officer
• Cesar Rivera, Head of Insurance and Pensions
• Rocio Benavides, Mibanco CFO
• Investor Relations Team

Participants are encouraged to pre-register for the listen-only webcast at the following link:
https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10204236&linkSecurityString=10040c5080c

Callers who pre-register will receive a conference passcode and unique PIN for immediate access to the call, bypassing the live operator. Participants may pre-register at any time, including up to and after the call begins.

Those unable to register may join the call by dialing:
Participant dial-in (USA/Canada toll-free): 1 844 435 0321
Participant international dial in: 1 412 317 5615
Participant Web Phone: Click Here
Conference ID: Credicorp Conference Call

A replay of the webcast will be available for one year on our Investor Relations website:
https://credicorp.gcs-web.com/events-and-presentations/past-events

Credicorp reminds you that we filed our Annual Report on Form 20-F for the fiscal year ended December 31 ^st , 2024 (2024 Form 20-F) with the Securities and Exchange Commission on April 25 ^th , 2025. The 2024 Form 20-F includes audited consolidated financial statements of Credicorp and its subsidiaries as of December 31 ^st , 2022, 2023 and 2024 under IFRS. Our 2024 Form 20- F can be downloaded from Credicorp’s website : https://credicorp.gcs-web.com/annual-materials Holders of Credicorp’s securities and any other interested parties may request a hard copy of our 2024 Form 20-F, free of charge, by filling out the form located on the link “mail request” on Credicorp’s website.

About Credicorp

Credicorp (NYSE: BAP) is the leading financial services holding company in Peru with presence in Chile, Colombia, Bolivia, and Panama. Credicorp has a diversified business portfolio organized into four lines of business: Universal Banking, through Banco de Crédito del Peru (“BCP”) and Banco de Crédito de Bolivia; Microfinance, through Mibanco in Peru and Colombia; Insurance & Pension Funds, through Grupo Pacifico and Prima AFP; and Investment Management & Advisory, through Credicorp Capital, Wealth Management at BCP and ASB Bank Corp. Credicorp has a presence in Peru, Chile, Colombia, Bolivia, and Panama.

For further information, please contact the IR team:

[email protected]

Investor Relations
Credicorp Ltd.

PHILADELPHIA and NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cohen & Company Inc. (NYSE American: COHN) will release its financial results for the third quarter 2025 on Tuesday, November 4, 2025. The Company will host a conference call at 10:00 a.m. Eastern Time (ET) that day to discuss these results.

The conference call will be available via webcast. Interested parties can access the webcast by clicking the webcast link on the Company’s homepage at www.cohenandcompany.com . Those wishing to listen to the conference call with operator assistance can dial (877) 524-8416 (domestic) or +1 (412) 902-1028 (international). A replay of the call will be available for three days following the call by dialing (877) 660-6853 or (201) 612-7415, with participant passcode 13756943.

About Cohen & Company

Cohen & Company is a financial services company specializing in an expanding range of capital markets and asset management services. Cohen & Company’s operating segments are Capital Markets, Asset Management, and Principal Investing. The Capital Markets segment consists of fixed income sales, trading, gestation repo financing, new issue placements in corporate and securitized products, underwriting, and advisory services, operating primarily through Cohen & Company’s subsidiaries, Cohen & Company Securities, LLC (“Cohen Securities”) in the United States and Cohen & Company Financial (Europe) S.A. in Europe. A division of Cohen Securities, Cohen & Company Capital Markets (“CCM”) is the Company’s full-service boutique investment bank that focuses on mergers and acquisitions (“M&A”), capital markets, and SPAC advisory services. The Capital Markets business segment also includes investment returns on financial instruments that the Company has received as consideration for advisory, underwriting, and new issue placement services provided by CCM. The Asset Management segment manages assets through collateralized debt obligations, managed accounts, joint ventures, and investment funds. As of September 30, 2025, the Company had approximately $1.4 billion of assets under management in primarily fixed income assets in a variety of asset classes including European bank and insurance trust preferred securities, debt issued by small and medium sized European, U.S., and Bermudian insurance and reinsurance companies, equity interests of SPACs and their sponsor entities, and commercial real estate loans. The Principal Investing segment is comprised primarily of investments the Company holds related to its SPAC franchise and other investments the Company has made for the purpose of earning an investment return rather than investments made to support its trading or other capital markets business activity. For more information, please visit www.cohenandcompany.com .

AUSTIN, Texas, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or (“Astrotech”), today announced that it has appointed Scott Bartley as Interim Chief Financial Officer (“CFO”) of the Company, effective as of October 20, 2025.

“We are pleased to announce Scott Bartley as Chief Financial Officer,” stated Thomas B. Pickens III, Chairman and Chief Executive Officer of Astrotech Corporation. “He brings over two decades of expertise as a Controller and CFO, across multiple industries, providing important qualification and vantage points for our business across multiple end markets.”
​
Mr. Bartley, age 56, has served as a financial consultant since 2011, including roles as Chief Financial Officer and controller for both public and private companies where he provided detailed accounting, reporting, fundraising and audit support. Mr. Bartley has served as a consultant at Bridgepoint Consulting since 2018. Previously, Mr. Bartley was owner and managing director of Tolarus Partners from 2013 to 2015 and Helix Advisors from 2011 to 2013 and again from 2015 to 2018, providing contract Chief Financial Officer and valuation services to technology, manufacturing and pharmaceutical clients. Mr. Bartley was Chief Financial Officer of Westlake Securities, a broker dealer from 2008 to 2011. Prior to Westlake Securities, Mr. Bartley was an Assurance Senior Manager at Deloitte & Touche, LLP.

Mr. Bartley is a Certified Public Accountant and Certified Valuation Analyst. He received a Bachelor of Business Administration and Master of Professional Accounting degree from the University of Texas at Austin.

About Astrotech Corporation
​
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that creates, operates, and scales innovative businesses through its wholly owned subsidiaries. Each subsidiary leverages Astrotech’s core technology to serve specialized markets:

• 1st Detect develops, manufactures, and markets trace detection systems for security and narcotics screening applications.
• AgLAB designs process analyzers tailored to the agriculture industry.
• Pro-Control produces solutions for in-situ chemical process control in industrial manufacturing.
• BreathTech is advancing a breath analysis platform to detect volatile organic compounds (VOCs) associated with infections and critical health conditions.
• EN-SCAN, Inc. delivers portable, ruggedized environmental testing solutions that integrate gas chromatography and mass spectrometry for use in challenging field environments.
  
  

Astrotech is headquartered in Austin, Texas. To learn more, visit www.astrotechcorp.com .
​
Forward-Looking Statements
​
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars in Ukraine and the middle east, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements in this document should be evaluated in light of these important risk factors. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Investor Contact:
Matt Kreps
Darrow Associates
(214) 597-8200
[email protected]

ATLANTA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its fourth quarter and full year ended September 30, 2025, after U.S. markets close on Thursday, November 6, 2025. On Friday, November 7, 2025, at 10:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website www.muellerwaterproducts.com . An archive of the webcast will be available for approximately 90 days following the call.

About Mueller Water Products, Inc .
Mueller Water Products, Inc. is a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America. Our broad portfolio includes engineered valves, fire hydrants, pipe connection and repair products, metering products, leak detection, pipe condition assessment, pressure management products, and software that provides critical water system data. We help municipalities increase operational efficiencies, improve customer service and prioritize capital spending, demonstrating why Mueller Water Products is Where Intelligence Meets Infrastructure ^® . Visit us at www.muellerwaterproducts.com .

Mueller refers to one or more of Mueller Water Products, Inc. (MWP), a Delaware corporation, and its subsidiaries. MWP and each of its subsidiaries are legally separate and independent entities when providing products and services. MWP does not provide products or services to third parties. MWP and each of its subsidiaries are liable only for their own acts and omissions and not those of each other.

Investor Relations Contact: Whit Kincaid
770-206-4116
[email protected]

Media Contact: Jenny Barabas
470-806-5771
[email protected]

Dallas, TX, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation services, reset the payment date of the previously-announced special dividend to Vivakor shareholders to December 31, 2025. The ex-dividend date was September 5, 2025. The dividend payment date was reset to accommodate the need to communicate and/or complete filings with the Securities and Exchange Commission in order to consummate the special dividend, which communications and filings cannot be completed during the government shutdown. The special dividend may be subject to additional delays if the government shutdown continues.

In accordance with NASDAQ listing rules, the dividend will be paid to holders of record of common shares of the Company as of the previously announced ex-dividend date of September 5, 2025.

Vivakor currently holds 206,595 shares of Adapti, Inc., a company that recently acquired a multi-platform sports agency representing amateuer and professional athletes at all levels that they intend to integrate with their pre-existing AdaptAI software platform that matches products with influencers to market athletic careers and associated branding opportunities. The acquired sports agency was previously owned by an entity controlled by James Ballengee, the Company’s Chairman, President and CEO.

About Vivakor, Inc.

Vivakor, Inc. is an integrated provider of transportation, storage, reuse, and remediation services. Its corporate mission is to develop, acquire, accumulate, and operate assets, properties, and technologies in the energy sector. Vivakor’s integrated facilities assets provide crude oil storage, transportation, future reuse, and remediation services under long-term contracts. Vivakor’s oilfield waste remediation facilities will facilitate the recovery, reuse, and disposal of petroleum byproducts and oilfield waste products.

For more information, please visit our website: http://vivakor.com

Cautionary Statement Regarding Forward-Looking Statements

This news release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements. Forward-looking statements may be identified but not limited by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” or “continue” and variations or similar expressions. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including, but not limited to, fluctuations in global and regional oil and gas prices and markets, the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect Vivakor, our ability to maintain the listing of our securities on The Nasdaq Capital Market , the parties failure to realize the anticipated benefits of pending transactions, disruption and volatility in the global currency, capital, and credit markets, changes in federal, local and foreign governmental regulation, changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, and general economic conditions.

These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor’s filings with the U.S. Securities and Exchange Commission, which factors may be incorporated herein by reference. Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. All information set forth herein speaks only as of the date hereof in the case of information about Vivakor or the date of such information in the case of information from persons other than Vivakor, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication. Forecasts and estimates regarding Vivakor’s industries and markets are based on sources we believe to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

Investors Contact:
P: 469-480-7175
[email protected]

ATLANTA, GA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- T Stamp Inc. dba Trust Stamp (Nasdaq: IDAI) a global provider of AI-powered identity services, today announced it has entered into a warrant inducement agreement with an existing institutional investor for the exercise and or exchange of certain outstanding warrants that the Company issued on September 3, 2024 (the “September Warrants”), December 6, 2024 (the “December Warrants”), and January 8, 2025 (the “January Warrants”). Pursuant to the warrant inducement agreement, the investor has agreed to (i) exercise all or a portion of the outstanding September 2024 Series A and Series B Warrants to purchase an aggregate of 413,696 shares of the Company's common stock at  an exercise price of $4.83 per share, (ii) exercise all or a portion of the January 2025 Series A and Series B Warrants to purchase an aggregate of 621,303 shares of the Company's common stock at  an exercise price of $8.45 per share, subject to compliance with  beneficial ownership blocker provisions included in the warrants and the Company agreed to reduce the exercise price on the September Warrants and January Warrants to $4.20 per share. In addition, the Company has agreed to exchange all outstanding December 2024 Warrants for New Warrants (as defined below). The gross proceeds from the exercise of the warrants are expected to be approximately $4.3 million, prior to deducting placement agent fees and estimated offering expenses.

Maxim Group LLC is acting as the Financial Advisor for the transaction.

In consideration for the exercise of the warrants, the Company also agreed to (i) issue to the investor unregistered Series A Warrants to purchase an aggregate of 1,301,945 shares of the Company's common stock and Series B Warrants to purchase an aggregate of 1,209,099 shares of the Company's common stock, each with an exercise price of $4.20 per share (the “New Warrants”) and (ii) exchange the investor’s December Warrants for a New Warrant to purchase up to a number of shares of Common Stock equal to 100% of the number of Warrant Shares issuable upon exercise of the December Warrants. The Series A and Series B warrants share substantially the same terms, are immediately exercisable, and will expire five years from the date of issuance. The Company has agreed to file a registration statement with the Securities and Exchange Commission (“SEC”) covering the resale of the shares of common stock issuable upon exercise of the New Warrants. This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About T Stamp Inc.

About Trust Stamp
Trust Stamp is a global provider of AI-powered services for use in multiple sectors, including banking and finance, regulatory compliance, government, healthcare, real estate, communications, and humanitarian services. Its technology empowers organizations via advanced solutions that reduce fraud, tokenize and secure data, securely authenticate users while protecting personal privacy, reduce friction in digital transactions, and increase operational efficiency, enabling customers to accelerate secure financial inclusion and reach and serve a broader base of users worldwide.

With team members from twenty-two nationalities in eight countries across North America, Europe, Asia, and Africa, Trust Stamp trades on the Nasdaq Capital Market (Nasdaq: IDAI).

Forward-Looking Statements

All statements in this release that are not based on historical fact are “forward-looking statements” including within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The information in this announcement may contain forward-looking statements and information related to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events-based information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

Investor Contacts
Email: [email protected]

WEST ORANGE, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- BEL FUSE INC. (NASDAQ:BELFA) and (NASDAQ:BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company's Class A common shares and $0.07 per share on the Company's Class B common shares.

Cash dividends for Class A and Class B common shares are payable on January 30, 2026 to shareholders of record on January 15, 2026.

Bel currently has approximately 12,660,000 common shares outstanding, of which 2,115,000 are Class A common shares and 10,545,000 are Class B common shares.

About Bel
Bel ( www.belfuse.com ) designs, manufactures and markets a broad array of products that power, protect and connect electronic circuits. These products are primarily used in the networking, telecommunications, computing, high-speed data transmission, military, commercial aerospace, transportation and e-Mobility industries. Bel’s portfolio of products also finds application in the automotive, medical and consumer electronics markets. Bel's product groups include Magnetic Solutions (integrated connector modules, power transformers, power inductors and discrete components), Power Solutions and Protection (front-end, board-mount and industrial power products, module products and circuit protection), and Connectivity Solutions (expanded beam fiber optic, copper-based, RF and RJ connectors and cable assemblies). The Company operates facilities around the world.

Investor Contact:
Steven Hooser or Jean Marie Young
Three Part Advisors, LLC
(631) 418-4339

Company Contact:
Mark Hodkinson
VP of Finance and Corporate Controller
[email protected]

New York, NY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital ( Nasdaq: ATON ), a specialized digital asset treasury company accelerating the growth of The Open Network (TON) ecosystem, today announced the launch of its global World Tour with an Investor Breakfast Meeting at the Nasdaq MarketSite in New York City on Monday, November 3, 2025 .

The exclusive event — “Introducing AlphaTON Capital: A New Frontier in Open Finance” — will feature presentations by Brittany Kaiser (CEO) , Enzo Villani (Chairman & Chief Investment Officer) , and Michael Terpin (Independent Board Member) . Together, they will outline AlphaTON’s mission to bridge institutional finance with the growing TON ecosystem and to bring Web3 access to over 1 billion users inside the world’s fastest-growing messaging platform, Telegram .

• $71 million raised to accelerate AlphaTON’s global strategy
• First TON Digital Asset Treasury (DAT) focused on M&A and ecosystem investments
• Expansion into gaming, DeFi, and Web3 accessibility
• Led by Brittany Kaiser , global data-rights activist and CEO

The Investor Breakfast Agenda will feature opening remarks by Brittany Kaiser, a market and investment strategy update from Enzo Villani, and a keynote on capital innovation and digital finance trends by Michael Terpin. The program concludes with a fireside chat exploring the future of money, governance, and law in the era of AI and blockchain.

“AlphaTON represents a new frontier in open finance,” said Brittany Kaiser, CEO of AlphaTON Capital. “We’re building a bridge between institutional capital and the TON ecosystem — empowering the next generation of global users through transparency, access, and innovation.”

About AlphaTON Capital Corp (NASDAQ: ATON)

AlphaTON Capital is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The Company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, AlphaTON Capital provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform while maintaining the governance standards and reporting transparency of a Nasdaq-listed company.

Led by Chief Executive Officer Brittany Kaiser and Chief Investment Officer, Enzo Villani, the company's activities span network validation and staking operations, development of Telegram-based applications, and potential strategic investments in TON-based decentralized finance protocols, gaming platforms, and business applications. AlphaTON Capital Corp is incorporated in the British Virgin Islands and trades on Nasdaq under the ticker symbol ATON .

AlphaTON Capital, through its legacy business, is also advancing potentially first-in-class therapies that target known checkpoint resistance pathways to potentially achieve durable treatment response and improve quality of life for patients. AlphaTON Capital actively engages in the drug development process and provides strategic counsel to guide development of novel immunotherapy assets and asset combinations.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements other than statements of historical fact, including statements regarding the Company's business strategy, plans and objectives, future operations, clinical development timelines, TON ecosystem growth, therapeutic development outcomes, regulatory approvals, financing activities, and statements preceded by, followed by, or including words such as "believe," "expects," "anticipates," "intends," "estimates," "will," "may," "plans," "potential," "targets," or similar expressions, are forward-looking statements.

These forward-looking statements are subject to substantial risks and uncertainties, including but not limited to: uncertainty regarding clinical trial outcomes and regulatory approvals; uncertainty of the Company's investment in TON and digital assets; regulatory and legal risks associated with digital assets; risks related to Telegram's platform and the TON ecosystem; market volatility; competitive risks in both digital assets and therapeutics development; and other factors described in "Item 3 – Key Information-Risk Factors" in the Company's Annual Report on Form 20-F for the year ended March 31, 2025, and subsequent reports filed with the Securities and Exchange Commission.

Although the Company believes the expectations reflected in these forward-looking statements are reasonable, actual results may differ materially. The Company undertakes no obligation to update publicly or revise any forward-looking statements, except as required by law.

Contact Information

Investor Relations
AlphaTON Capital Corp
[email protected]
(203) 682-8200

Media Inquiries
Richard Laermer
RLM PR
[email protected]
(212) 741-5106 X 216

BOCA RATON, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DFDV” or the “Company”), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced it will host a live X Spaces event on Monday, November 3, 2025, at 5:00 PM ET.

The event will provide shareholders, analysts, and the broader community with a comprehensive recap of DFDV’s progress during October 2025, including recent capital markets activity, the launch of weekly options on CBOE, international expansion, continued growth of treasury holdings, recent industry developments, and more.

Participants can join the live event by visiting DeFi Development Corp.’s official X account at the scheduled time. A recording of the conversation will be made available shortly after the event concludes.

Join the conversation: https://x.com/i/spaces/1vAxRQXBmDVJl .

The Company does not intend to disclose any material nonpublic information during the event.

About DeFi Development Corp.
DeFi Development Corp. (Nasdaq: DFDV) has adopted a treasury policy under which the principal holding in its treasury reserve is allocated to Solana (SOL). Through this strategy, the Company provides investors with direct economic exposure to SOL, while also actively participating in the growth of the Solana ecosystem. In addition to holding and staking SOL, DeFi Development Corp. operates its own validator infrastructure, generating staking rewards and fees from delegated stake. The Company is also engaged across decentralized finance (DeFi) opportunities and continues to explore innovative ways to support and benefit from Solana’s expanding application layer.

The Company is an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions, as well as value-add services, to multifamily and commercial property professionals, as the Company connects the increasingly complex ecosystem that stakeholders have to manage.

The Company currently serves more than one million web users annually, including multifamily and commercial property owners and developers applying for billions of dollars of debt financing per year, professional service providers, and thousands of multifamily and commercial property lenders, including more than 10% of the banks in America, credit unions, real estate investment trusts (“REITs”), debt funds, Fannie Mae® and Freddie Mac® multifamily lenders, FHA multifamily lenders, commercial mortgage-backed securities (“CMBS”) lenders, Small Business Administration (“SBA”) lenders, and more. The Company’s data and software offerings are generally offered on a subscription basis as software as a service (“SaaS”).

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," strategy," "future," "likely," "may,", "should," "will" and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations, and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) fluctuations in the market price of SOL and any associated impairment charges that the Company may incur as a result of a decrease in the market price of SOL below the value at which the Company’s SOL are carried on its balance sheet; (ii) volatility in our stock price, including due to future issuances of common stock and securities convertible into common stock; (iii) the effect of and uncertainties related the ongoing volatility in interest rates; (iv) our ability to achieve and maintain profitability in the future; (v) the impact on our business of the regulatory environment and complexities with compliance related to such environment including changes in securities laws or other laws or regulations; (vi) changes in the accounting treatment relating to the Company’s SOL holdings; (vii) our ability to respond to general economic conditions; (vii) our ability to manage our growth effectively and our expectations regarding the development and expansion of our business; (ix) our ability to access sources of capital, including debt financing and other sources of capital to finance operations and growth and (x) other risks and uncertainties more fully in the section captioned “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and other reports we file with the SEC. As a result of these matters, changes in facts, assumptions not being realized, or other circumstances, the Company's actual results may differ materially from the expected results discussed in the forward-looking statements contained in this press release. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Investor Contact:
[email protected]

Media Contact:
[email protected]

CHICAGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the initiation of a new research and development program leveraging nanotechnology to enhance the effectiveness of phytochemical constituents used in its dietary supplement formulas.

This new initiative builds upon the proprietary know-how developed during the creation of CCX Hydrogel, a breakthrough platform for optimised bioactive delivery. The Company is now expanding its innovation pipeline by developing plant-based extract-loaded phytosomes intended for use in dietary supplements. These nanostructured systems are designed to significantly improve the absorption, stability, and bioactivity of phytochemicals, leading to measurable efficacy improvements.

The approach follows a sustainable, solvent-free process, emphasising environmentally responsible, green formation of phytosomes that are fully suitable for incorporation into nutraceutical applications. This aligns with Cosmos Health’s broader commitment to sustainable innovation, scientific advancement, and responsible manufacturing.

Figure: Stability assessment of the produced phytosomes using Nanoparticle Tracking Analysis.

Greg Siokas, CEO of Cosmos Health, stated: “Our platform represents a promising step toward the development of sustainable, bioactive-enriched food technologies. By combining nanotechnology with advanced phytochemical formulations, we aim to deliver next-generation dietary supplements with validated functional performance and enhanced consumer benefits.”

Dr Panagiotis Zoumpoulakis, Head of Research & Development at Cosmos Health, added : “The integration of nanotechnology into our R&D strategy enables us to explore the full potential of phytochemicals at the molecular level. Through precise nanoscale engineering, we can optimise how these bioactive compounds are absorbed and interact within the body, resulting in superior effectiveness and consistency. This marks a significant advancement in our pursuit of scientifically driven nutraceutical innovation.”

About Cosmos Health Inc.

Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X .

Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website ( www.sec.gov ). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise

Investor Relations Contact:
BDG Communications
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b1d0d0db-c193-4646-afde-136e62431eb8

PHOENIX, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Fold Holdings, Inc. (NASDAQ: FLD) (“Fold” or the “Company”), a bitcoin financial services company making it easy for individuals and businesses to earn, save, and spend bitcoin through everyday financial tools, today announced a landmark partnership with Steak ’n Shake that brings bitcoin directly to dining, rewarding customers with $5 in bitcoin when they order the Steak ‘n Shake Bitcoin Meal or Bitcoin Steakburger.

The limited-time offer is available at its approximately 400 Steak ’n Shake locations nationwide, giving guests a delicious new way to earn bitcoin. This marks the first time a U.S. restaurant chain has bundled meals with bitcoin rewards, a milestone signaling how quickly bitcoin is moving from niche investment to mainstream culture.

Customers who purchase a Bitcoin Burger or Bitcoin Meal can visit www.bitcoinmealdeal.com, upload their receipt, and receive a unique code redeemable for $5 in bitcoin through the Fold app. After downloading the Fold app and activating an account, users can redeem their $5 bitcoin reward and start earning bitcoin on future everyday purchases. Each customer may redeem one code, subject to applicable terms and conditions.

“Bitcoin goes mainstream when it starts showing up in everyday life,” said Will Reeves, Chairman, CEO and Founder of Fold. “That’s been our vision from the beginning and our promotion with Steak ’n Shake is the next step in that journey. For many people, this will be the first time they ever own bitcoin, and it will come from something as ordinary as grabbing a burger. That’s what real adoption looks like.”

The campaign will roll out nationwide today, October 31st and will run while supplies last. This initiative represents the first in a series of mainstream partnerships Fold plans to announce in the coming months, all designed to make bitcoin simple, rewarding, and part of everyday life.

About Steak n Shake
Steak ‘n Shake is a classic American brand born on Route 66 in 1934. They are the creators of the Steakburger, extraordinary homemade milkshakes, and famous beef tallow fries. Steak ‘n Shake uses higher quality ingredients and cares about its people by proudly being the maximum wage employer. They seek to lead in food quality and service and embrace leading technologies such as Bitcoin. Steak ‘n Shake is proud to be an American company.  For more information, visit https://steaknshake.com/ or connect with them on social media at @SteaknShake.

About Fold
Fold (NASDAQ: FLD) is the first publicly traded bitcoin financial services company, making it easy for individuals and businesses to earn, save, and use bitcoin. With nearly 1,500 BTC in its treasury, Fold is at the forefront of integrating bitcoin into everyday financial experiences. Through innovative products like the Fold App, Fold Credit Card™, Fold Bitcoin Gift Card™, and Fold Debit Card™, the company is building the bridge between traditional finance and the bitcoin-powered future.

For investor inquiries, please contact:
Orange Group
Samir Jain, CFA
[email protected]

For media inquiries, please contact:
Jessica Starman, MBA
[email protected]

RIYADH, Oct. 31, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”), the RedAI trading platform used by Fast Moving Consumer Goods (‘FMCG’) businesses, announced the outcome of the Future Investment Initiative (FII9) in Riyadh, Saudi Arabia, where it held a formal signing ceremony to seal its landmark joint venture agreement with Kayanat Holding, and held more than one hundred meetings as part of preparations for Saudi launch.

The formal signing ceremony, live on day three of the FII9 event, marked a pivotal milestone in RedCloud’s expansion into the Kingdom—aligning with Saudi Vision 2030 and the country’s strategic focus on digital transformation and supply chain modernization. The joint venture, RedCloud Arabia, will deploy RedAI’s algorithmic infrastructure to digitize and transform FMCG trade across the country.

The Company and Kayanat held joint meetings with key players within the Saudi FMCG Industry—who are believed to represent around 20% of the $61Bn market ³ —supporting a targeted launch date of December 2025.

“FII9 was a catalytic event for RedCloud, where we heard from industry leaders to heads of state who shared our concern for global trading challenges including spiraling consumer prices and the waste of critical resources,” said Justin Floyd, CEO and Founder of RedCloud. “Bloomberg built the intelligence foundation for financial markets. Google built it for the internet. Supply chains are next. The Kingdom of Saudi Arabia will be a pioneer and leader in solving this problem and we are delighted to work with Majid and his team on expanding RedCloud’s intelligence foundation for global trade, moving human guesswork and manual trading to algorithmic transformation.”

“For nearly 90 years, Saudi Arabia has powered the world through reliable and affordable energy supply chains. Today, that same advantage will fuel the world’s AI factories,” added Majid Alghaslan, Founder of Kayanat. “Our collaboration with RedCloud reflects Vision 2030’s ambition to transform the Kingdom into a global hub where technology, data, and intelligence redefine trade—building predictive, autonomous, and sustainable economies of the future.”

RedCloud Arabia intends to focus on localizing RedAI’s capabilities to serve Saudi distributors, retailers, and manufacturers, enabling smarter purchasing decisions and addressing inventory shortfalls. The Company believes that traditional AI and LLMs train on public internet data, while RedCloud trains its models on private b2b supply chain data that can’t be accessed by the AI incumbents. The Company’s platform has already demonstrated success in high-growth markets such as Nigeria, Brazil, and South Africa, and is now poised to bring similar impact to the Middle East.

The announcement follows significant operational momentum for RedCloud: the Company more than doubled customer numbers year-over-year in the first half of 2025, launched a new partnership strategy for payments and financial services to maximize working capital across supply chains, and expanded its technology ecosystem through the NVIDIA Connect program alongside existing partnerships with AWS and Snowflake.

FII9 convened around 600 global leaders ⁴ including heads of state, speakers and innovators under the theme “The Key to Prosperity: Unlocking New Frontiers of Growth.” RedCloud’s presence at the event underscored its commitment to building the intelligence foundation for the FMCG industry—from manufacturer to retailer—within Saudi Arabia, the Middle East, and beyond.

For more information or photographs from the JV signing at FII9, please use the media relations contact details below.

About RedCloud Holdings plc
RedCloud has developed and operates the RedAI trading platform (“RedAI”), that facilitates the trading of everyday consumer supplies of fast-moving consumer goods (“FMCG”) products across business supply chains. RedCloud believes its Platform solves a decades old problem of how to unlock and enable access to key purchase and sales data between supply-chain businesses in high growth consumer markets.

Through RedCloud’s Platform, retailers are empowered by data driven market insights backed by artificial intelligence (“AI”) to help make faster and easier business-to-business (“B2B”) purchases and inventory decisions from brands and distributors by breaking down complex purchasing behaviors of large product inventory catalogues. For more information about RedCloud and its Platform, please visit https://investors.redcloudtechnology.com and connect on LinkedIn .

About Kayanat
Kayanat Holding, led by Majid Alghaslan, is a family office, and a visionary enterprise driven by a quest for wisdom, innovation, and stewardship over nature and technology. Guided by values of integrity, knowledge, and harmony, we invest in advanced fields such as AI, autonomous systems, energy, space, security, and sustainability, aspiring to harness these tools to serve humanity and honor the world around us.

In alignment with Saudi Vision 2030, Kayanat is dedicated to building local expertise and fostering a self-sustaining economy through the localization of products and services. We seek to inspire growth, create meaningful opportunities, and ensure our ventures leave a positive, lasting impact on society and the environment — contributing to a legacy of progress, stewardship, and enduring prosperity.

Forward-Looking Statements
The information in this press release may include forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or our future financial or operating performance. When used in this press release, words such as “expect,” “project,” “estimate,” “believe,” “anticipate,” “intend,” “plan,” “seek,” “forecast,” “target,” “predict,” “may,” “should,” “would,” “could,” and “will,” the negative of these terms and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Forward-looking statements are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict, including, but not limited to, the continued growth of the Company’s customer base, customers’ purchasing behavior and requisite needs, the Company’s ability to continue to provide distributors and retailers with adequate resources to conduct their business, the effectiveness of collected data through the RedAI Trading Platform to provide transparency and choice to supply chains. As a result, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in RedCloud’s described in “Cautionary Note Regarding Forward-Looking Statements,” “Item 3. Key Information – D. Risk Factors” and “Item 5. Operating and Financial Review and Prospects” in RedCloud’s Annual Report on Form 20-F for the year ended December 31, 2024, which was filed with the Securities and Exchange Commission (the “SEC”) on May 16, 2025, as well as other documents filed by the Company with the SEC. RedCloud undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Information contained on, or that can be accessed through, the Company's website or any other website or any social media is expressly not incorporated by reference into and is not a part of this press release.

Footnotes:
[1] $61Bn estimated Saudi FMCG Market in 2024, based on average of Deep Market Insights Report and Aviaan Research .

[2] Estimated $8.7Bn Saudi Arabian Inventory Gap calculated from $2Tn Estimated Global Inventory Gap from IHL Research , applied in proportion to Saudi Arabian FMCG Market ² .

[3] The Company in active discussion with manufacturers and distributors estimated to represent 19.67% ($12Bn revenue) of Saudi FMCG Market value ($61Bn ¹ )

[4] Attendees at FII9 Event FII Institute Announces Record Participation at FII9

Contacts:

Investor Relations
Ryan Flanagan
[email protected]

Media Relations
JOTO PR
[email protected]

GEELONG, Australia, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that it has reached agreement with Orion Infrastructure Capital (“OIC”) to provide a further up to US$7 million of funding. The Company also reports the cancellation of two electric vehicle (“EV”) wheel programs, which is consistent with the weakening of demand across the broader EV market.

Further US$7 million of OIC funding

Of the up to US$7 million of OIC funding, US$5 million was released on October 31, 2025, in exchange for the issuance of additional senior secured notes. The notes will have substantially the same terms as the Company’s existing senior secured notes outstanding (the “Existing Notes”). In connection with this funding tranche, the Company will also issue to OIC penny warrants to purchase an aggregate number of shares equal to 5.0% of the Company’s shares outstanding.

The release of the second US$2 million tranche of funding is subject to the agreement of both parties, with funding to occur on a date no earlier than March 31, 2026. As part of this funding, both OIC and the holders of Existing Notes have agreed to partial payment in kind, in lieu of cash, for certain interest payments until July 2026 and a further deferral of the commencement of principal repayments to January 2027.

Program cancellations and important business update

As previously disclosed in the Company’s release of July 25, 2025, the Company has a number of new programs entering, or expected to enter, production in the near-term, however, as a result of a decline in the volume of wheels ordered or projected to be ordered by certain customers, the Company revised its revenue forecasts downward and slowed its initial short-term expansion plans.

The Company has continued to experience lower than expected demand for certain programs, especially those tied to the EV space. The weakening of the broader EV market has led to the early cancellation of two programs by a customer, which the Company had initially expected to contribute substantial wheel volumes. The Company is pursuing claims in relation to these cancelled programs.

In addition, as disclosed in the Company’s release of June 3, 2025, the Company is currently not in compliance with certain Nasdaq continued listing requirements. The Company has submitted a plan of compliance to Nasdaq where it has sought an extension in accordance with its plan and is waiting for Nasdaq’s determination. However, even if such plan is accepted, the Nasdaq staff only has the discretion to grant an exception for regaining compliance until November 26, 2025.

Notwithstanding the additional US$5 million of OIC funding announced today (and the expected release of a further US$2 million of OIC funding), the Company expects that it may need to obtain additional funding in the short term and is actively seeking other strategic alternatives to be completed within this fiscal year (ending June 30, 2026).

In order to obtain sufficient liquidity to fund its business and operations, the extent of which funding need is partially dependent upon the outcome of the customer claims being pursued by the Company mentioned above, as well as to contribute towards regaining compliance with Nasdaq continued listing requirements, the Company is exploring other potential strategic and financing options, a portion of which may need to be obtained significantly earlier than the end of the Company’s fiscal year. The Company makes no assurances that it will be able to secure any of the aforementioned on satisfactory terms, or at all.

About Carbon Revolution plc

Carbon Revolution plc (Nasdaq: CREV) (the “Company” or “Carbon Revolution”) is the parent of Carbon Revolution Pty Ltd, an early-stage growth company which has successfully innovated, commercialized and industrialized the advanced manufacture of carbon fiber wheels for the global automotive industry. The Company has progressed from single prototypes to designing and manufacturing lightweight wheels for cars and SUVs in the high performance, premium and luxury segments, for the world’s most prestigious automotive brands. Carbon Revolution is creating a significant and sustainable advanced technology business that supplies its lightweight wheel technology to automotive manufacturers around the world.

For more information, visit carbonrev.com

Forward Looking Statements

All statements other than statements of historical facts contained in this communication are forward-looking statements. Forward-looking statements may generally be identified by the use of words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” “target” or other similar expressions (or the negative versions of such words or expressions) that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, the future financial performance, business strategies, financings, potential strategic transactions, ability to regain compliance with Nasdaq continued listing requirements and expectations for the Company’s business. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Carbon Revolution’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from such assumptions, and such differences may be material. Many actual events and circumstances are beyond the control of Carbon Revolution.

These forward-looking statements are subject to a number of risks and uncertainties, including (i) the ability to maintain the listing of Carbon Revolution’s securities on Nasdaq or any other exchange on which such securities may be listed in the future; (ii) the failure to realize the benefits of being listed on a U.S. securities exchange and publicly-traded in the United States; (iii) Carbon Revolution's liquidity, including its ability to pay its obligations and to issue equity, refinance its indebtedness or otherwise obtain financing or complete a strategic transaction at all or on acceptable terms, (iv) risks related to its ability to meet financial covenants and other key covenants under existing financing arrangements or to obtain waivers or forbearance from compliance with such covenants, which could result in the acceleration of outstanding indebtedness, (v) changes in domestic and foreign business, market, financial, political and legal conditions; (vi) risks related to the rollout of Carbon Revolution’s business strategy and the timing of expected business milestones; (vii) the effects of competition on Carbon Revolution’s future business and the ability of the combined company to grow and manage growth, establish and maintain relationships with customers and retain its management and key employees; (viii) risks related to domestic and international political and macroeconomic uncertainty, including the Russia-Ukraine conflict and conflicts in the Middle East; (ix) the outcome of any legal proceedings that may be instituted against Carbon Revolution; (x) the impact of pandemic and governmental responses on any of the foregoing risks; (xi) risks related to Carbon Revolution’s industry; (xii) changes in laws and regulations; and (xiii) those factors discussed in the documents Carbon Revolution filed with the SEC, including Carbon Revolution’s Annual Report on Form 20-F.

If any of these risks materialize or Carbon Revolution’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Carbon Revolution does not presently know or that Carbon Revolution currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Carbon Revolution’s expectations, plans or forecasts of future events and views as of the date of this communication. Carbon Revolution anticipates that subsequent events and developments will cause Carbon Revolution’s assessments to change. However, while Carbon Revolution may elect to update these forward-looking statements at some point in the future, Carbon Revolution specifically disclaims any obligation to do so, unless required by applicable law. These forward-looking statements should not be relied upon as representing Carbon Revolution’s assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.

For further information, please contact:

Investors
[email protected]

Media
[email protected]

Newport, Rhode Island, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Audrain Concours Foundation and Audrain Motorsport today announced a landmark partnership with Broad Arrow Auctions, a Hagerty Company (NYSE: HGTY), establishing the collector car auction house as the exclusive auction partner for the Audrain Newport Concours & Motor Week and presenting sponsor of the Audrain Motorsport Veteran Car Tour through 2028.

The agreement marks a significant expansion for Broad Arrow Auctions, representing the company's only auction presence in the Northeast and establishing Newport as the centerpiece of its regional strategy. The partnership aligns Broad Arrow with what has become the Northeast's premier automotive destination and one of the most significant events on the national automotive calendar, offering year-round engagement with the collector car community across two distinctive experiences spanning spring and fall.

"This partnership represents Broad Arrow's continued expansion and a commitment to establishing deep roots in the Northeast collector car market," said Kenneth Ahn, President of Hagerty Marketplace and Broad Arrow . "Audrain has built the region's most significant automotive events, and we are honored to partner with Audrain to engage with collectors and enthusiasts at one of the most important destinations in the U.S. automotive calendar—an environment that celebrates automotive history, craftsmanship, and community."

The collaboration integrates Broad Arrow’s collector car expertise and market leadership with Audrain's mission to create inclusive, welcoming experiences that celebrate automotive history, luxury, and sport. Both organizations share a commitment to making collector car culture accessible to enthusiasts at every level while maintaining the highest standards of curation and presentation.

Audrain Newport Concours & Motor Week

As the exclusive auction partner for the Audrain Newport Concours & Motor Week each October, Broad Arrow will conduct a premier collector car auction at the International Tennis Hall of Fame during the four-day celebration. The partnership also designates Broad Arrow as presenting sponsor of the Audrain Automobile Museum Gala , one of the automotive world's most prestigious social events.

The October event attracts collectors, enthusiasts, and industry leaders from around the world to Newport's historic Bellevue Avenue, featuring world-class concours judging, automotive exhibitions, and now, a curated auction of desirable collector vehicles. The scale and scope of Audrain Newport Concours & Motor Week has established it as the Northeast's flagship automotive gathering and a cornerstone of the national collector car calendar.

Audrain Motorsport Veteran Car Tour

Each May, the Audrain Motorsport Veteran Car Tour Presented by Broad Arrow Auctions showcases pre-1916 veteran-era automobiles throughout Newport County's scenic coastal roads. The tour celebrates automotive pioneering spirit and the region's rich motorsport heritage, offering participants and spectators an intimate experience with automotive history.

Broad Arrow's presenting sponsorship brings the company's expertise and enthusiasm to one of America's most charming motoring events.

Establishing Newport as the Northeast's Premier Automotive Destination

The partnership solidifies Newport, Rhode Island's position as the Northeast's premier destination for automotive events and collector car culture.

"Broad Arrow's commitment to Newport and to both our Concours & Motor Week and Veteran Tour demonstrates their vision for long-term partnership," said Nic Waller, President of The Audrain Group . "Together, we're building something enduring—a year-round destination where collectors, historians, enthusiasts, and newcomers can all find their place in the automotive community. This partnership recognizes what Audrain has built: the Northeast's most significant automotive gathering and one of the premier events on the national calendar."

The partnership commences with the 2026 event season and extends through 2028, with both spring and fall activations each year.

About Audrain

Audrain Concours Foundation and Audrain Motorsport are dedicated to advancing public appreciation of automotive history, design, and culture through world-class events and educational programming. Based in Newport, Rhode Island, Audrain produces the annual Audrain Newport Concours & Motor Week each October and the Audrain Motorsport Veteran Car Tour each May, alongside year-round activities at the Audrain Automobile Museum. Audrain is committed to creating inclusive, welcoming experiences that celebrate automotive excellence while making collector car culture accessible to enthusiasts of all backgrounds.

About Broad Arrow Auctions

Broad Arrow Auctions, a Hagerty (NYSE: HGTY) company, is a leading global collector car auction house. Founded in 2021 by highly experienced industry veterans, Broad Arrow offers exceptional quality cars to collectors and enthusiasts around the world. As the fastest growing auction house in its segment, Broad Arrow’s flagship annual events include The Monterey Jet Center Auction, in conjunction with Motorlux in California, The Amelia Auction, as the official auction of The Amelia (Concours d’Elegance) in Florida, and The Porsche Auction, in conjunction with Air | Water by Luftgekühlt in California. Broad Arrow expanded its global footprint in 2023, with renowned car specialists joining the team in the UK and Europe. Broad Arrow launched its first auction in Europe in May 2025 as the new official auction house of the Concorso d’Eleganza Villa d’Este in Italy in partnership with BMW AG. Broad Arrow expanded its global auction footprint with three new auctions in 2025 held during Zoute Grand Prix, Concours at Wynn Las Vegas, and Auto Zürich. Learn more at broadarrowauctions.com and follow us on Instagram , Facebook , LinkedIn , and Twitter .

Attachments

• A snapshot of the 2025 Audrain Newport Concours, which will feature Broad Arrow as exclusive auction partner beginning in 2026.
• A snapshot of the 2025 Audrain Newport Concours, which will feature Broad Arrow as exclusive auction partner beginning in 2026.

SAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that it will release its financial results for the third quarter ended September 30, 2025, after the market close on Monday, November 10, 2025. Management will then host a webcast and conference call at 4:30 p.m. ET on the same day.

A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company’s website .

About Capricor Therapeutics

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. At the forefront of our innovation is our lead product candidate, Deramiocel, an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for the treatment of Duchenne muscular dystrophy (DMD). Extensive preclinical and clinical data have demonstrated Deramiocel’s potent immunomodulatory and anti-fibrotic effects in helping to preserve cardiac and skeletal muscle function in DMD. Capricor is also leveraging the power of its exosome technology, using its proprietary StealthX™ platform in preclinical development focused on vaccinology and the targeted delivery of oligonucleotides, proteins, and small-molecule therapeutics, with the potential to treat and prevent a wide range of diseases. At Capricor, we are committed to pushing the boundaries of possibility and forging a path toward transformative treatments for those in need. For more information, visit capricor.com , and follow Capricor on Facebook , Instagram and X .

Cautionary Note Regarding Forward-Looking Statements

Statements in this press release regarding the efficacy, safety, and intended utilization of Capricor’s product candidates; the initiation, conduct, size, timing and results of clinical trials; the pace of enrollment of clinical trials; plans regarding regulatory filings, future research and clinical trials; regulatory developments involving products, including future interactions with regulatory authorities and the ability to obtain regulatory approvals or otherwise bring products to market; manufacturing capabilities; dates for regulatory meetings; the potential that required regulatory inspections may be delayed or not be successful, which would delay or prevent product approval; the ability to achieve product milestones and to receive milestone payments from commercial partners; and any other statements about Capricor’s management team’s future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “could,” “anticipates,” “expects,” “estimates,” “should,” “target,” “will,” “would” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements. More information about these and other risks that may impact Capricor’s business is set forth in Capricor’s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission on March 26, 2025, and in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission on August 11, 2025. All forward-looking statements in this press release are based on information available to Capricor as of the date hereof, and Capricor assumes no obligation to update these forward-looking statements.

Capricor has entered into an agreement for the exclusive commercialization and distribution of Deramiocel for DMD in the United States and Japan with Nippon Shinyaku Co., Ltd. (U.S. subsidiary: NS Pharma, Inc.), subject to regulatory approval. Deramiocel and the StealthX™ vaccine are investigational candidates and have not been approved for commercial use in any indication.

For more information, please contact:

Capricor Media Contact:
Raquel Cona
KCSA Strategic Communications
[email protected]
212.896.1204

Capricor Company Contact:
AJ Bergmann, Chief Financial Officer
[email protected]
858.727.1755

PITTSBURGH, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) and Frontier Power Ltd. (“Frontier”), a leading UK-based energy developer, today announced a strategic 228 megawatt-hour (MWh) order to deploy Eos Z3™ energy storage systems across Frontier’s expanding portfolio of storage and grid-reliability projects.

The 228 MWh order – the first to be converted under the companies’ 5 GWh framework agreement announced in April 2025 – marks a significant milestone in a growing partnership focused on scaling alternative, long-duration energy storage to strengthen grid reliability across multiple markets.

“This order reflects continued confidence in Eos’ zinc technology and the strength of our partnership with Frontier,” said Nathan Kroeker, Eos Chief Commercial Officer. “Together, we’re demonstrating that long-duration storage is ready to scale and play a critical role in delivering reliable dispatchable power.”

Frontier will deploy Eos’ Z3™ energy storage systems, featuring the Company’s proprietary battery management system, software, controls and analytics platform – DawnOS™ – to validate performance and reliability in diverse grid environments. This provides a unique opportunity to showcase Eos’ technology ahead of Frontier’s upcoming projects under Ofgem’s Cap-and-Floor program.

Frontier recently advanced 11 gigawatt-hours (GWh) of long-duration storage projects to the second round of the program, all incorporating Eos’ technology and more than double the original commitment. This milestone highlights the growing market demand for 8-hour-plus storage and reinforces confidence in the companies’ joint ability to deliver commercially viable, large-scale solutions.

“Our partnership with Eos goes beyond a single project – it’s about building a platform for long-duration storage at scale,” said Humza Malik, Frontier Chief Executive Officer. “Together, we’re demonstrating how innovative, safe, and sustainable zinc technology can support renewable growth and deliver dependable, flexible power for the grid of the future.”

Eos’ Z3™ technology builds on the company’s proven zinc-based chemistry, offering enhanced energy density, extended duration, and a safe, non-flammable solution ideal for long-life, grid-scale applications. As the partnership grows, Eos and Frontier are positioned to accelerate deployment of long-duration energy storage across key international markets, supporting renewable integration, grid stability, and global energy security.

The announcement coincides with the Company also achieving its final cash receipt milestone previously agreed upon between Eos and an affiliate of Cerberus Capital Management LP (Cerberus) as part of Cerberus’s strategic investment in the Company. No additional preferred stock or warrants will be issued to Cerberus at this time.

About Eos Energy Enterprises

Eos is accelerating the shift to American energy independence with positively ingenious solutions that transform how the world stores power. The Company’s BESS features the innovative Znyth™ technology, a proven chemistry with readily available non-precious earth components, that is the pre-eminent safe, non-flammable, secure, stable, and scalable alternative to conventional lithium-ion technology. The Company’s BESS is ideal for utility-scale, microgrid, commercial, and industrial long-duration energy storage applications (i.e., 4 to 16+ hours) and provides customers with significant operational flexibility to cost effectively address current and future increased grid demand and complexity. For more information about Eos (NASDAQ: EOSE), visit eose.com .

Contacts
Investors: [email protected]
Media: [email protected]

Forward Looking Statements

Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements that refer to outlook, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on our management’s beliefs, as well as assumptions made by, and the information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected.

Factors which may cause actual results to differ materially from current expectations include, but are not limited to: changes adversely affecting the business in which we are engaged; our ability to forecast trends accurately; our ability to generate cash, service indebtedness and incur additional indebtedness; our ability to achieve the operational milestones on the delayed draw term loan; our ability to raise financing in the future; risks associated with the credit agreement with Cerberus, including risks of default, dilution of outstanding Common Stock, consequences for failure to meet milestones and contractual lockup of shares; our customers’ ability to secure project financing; the amount of final tax credits available to our customers or to Eos pursuant to the Inflation Reduction Act; the timing and availability of future funding under the Department of Energy Loan Facility; our ability to continue to develop efficient manufacturing processes to scale and to forecast related costs and efficiencies accurately; fluctuations in our revenue and operating results; competition from existing or new competitors; our ability to convert firm order backlog and pipeline to revenue; risks associated with security breaches in our information technology systems; risks related to legal proceedings or claims; risks associated with evolving energy policies in the United States and other countries and the potential costs of regulatory compliance; risks associated with changes to the U.S. trade environment; our ability to maintain the listing of our shares of common stock on NASDAQ; our ability to grow our business and manage growth profitably, maintain relationships with customers and suppliers and retain our management and key employees; risks related to the adverse changes in general economic conditions, including inflationary pressures and increased interest rates; risk from supply chain disruptions and other impacts of geopolitical conflict; changes in applicable laws or regulations; the possibility that Eos may be adversely affected by other economic, business, and/or competitive factors; other factors beyond our control; risks related to adverse changes in general economic conditions; and other risks and uncertainties.

The forward-looking statements contained in this press release are also subject to additional risks, uncertainties, and factors, including those more fully described in the Company’s most recent filings with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. Further information on potential risks that could affect actual results will be included in the subsequent periodic and current reports and other filings that the Company makes with the Securities and Exchange Commission from time to time. Moreover, the Company operates in a very competitive and rapidly changing environment, and new risks and uncertainties may emerge that could have an impact on the forward-looking statements contained in this press release.

Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Appointment adds Global leadership experience with backgrounds in commodity Trading, specifically the supply of gold and commodity-based trade finance

Will deepen Blue Gold’s expertise in scaling the Gold Trading business, managing public companies, and driving shareholder value

Advisory Board positioned to support Blue Gold’s next phase of operational growth and expansion

NEW YORK, NY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Blue Gold Limited (Nasdaq: BGL) ("Blue Gold" or the “Company”), a next-generation gold development and technology company, today announced the Appointment of Jagdish M. Chanrai to the Advisory Board. The initiative supports Blue Gold’s mission to pioneer the digitization of real-world assets (RWAs), including gold, while responding to the accelerating demand for decentralized financial instruments. Blue Gold’s planned gold token is designed to deliver a transparent, auditable, and liquid gold currency.

Mr. Chanrai is a seasoned business leader with deep experience in emerging market operations, cross-border commerce, and governance. He played a strategic role in building and overseeing complex supply chains across Africa, the Middle East, & Asia. Jagdish Chanrai is the Chairman of Hudson Dunes Corporation a vertically integrated commodity trading house and Director of the Kewalram Chanrai Group (KCG), serving on the management board of the holding company. KCG is family-owned and professionally managed. It has interests in supply chain management, textiles, real estate, agriculture, environmentally friendly products, and founded Olam Group in 1989, which was later acquired by Temasek Holdings.

Mr. Chanrai stated, “I’m excited to collaborate with the Blue Gold team on both the Trading of Gold and the Tokenization of Gold. Institutional and retail investors alike are increasingly turning to digital Gold tokens as a hedge against depreciating fiat currencies and volatile cryptocurrency prices. Blue Gold Coin will demonstrate that real-world assets can prosper on-chain."

Andrew Cavaghan, CEO of Blue Gold, welcomed the appointment, “Jagdish’s wealth of experience across trade and commodities, especially in the Middle East and North African markets, lines up really well with the strategic focus we have set for ourselves,” said Andrew “We’re excited to bring him alongside our other Advisory Board members as we put the building blocks in place to deliver our vertically integrated business plan."

Mr. Chanrai further stated, "With gold prices at all-time highs and institutional interest in tokenized assets growing, Blue Gold can deliver a new model for the future of Gold ownership."

The Company plans to announce additional milestones in the delivery of its strategy in the coming weeks.

About Blue Gold Limited
Blue Gold Limited (Nasdaq: BGL) is a next-generation gold development company focused on acquiring and aggregating high-potential mining assets across strategic global jurisdictions. The Company’s mission is to unlock untapped value in the gold sector by combining disciplined resource acquisition with innovative monetization models, including asset-backed digital instruments. Blue Gold is committed to responsible development, operational transparency, and leveraging modern financial technologies to redefine how gold is produced, accessed, and owned in the 21st century.

Blue Gold prioritizes growth, sustainable development, and transparency in all our business practices. We believe that our commitment to responsible mining will enable us to create value for our shareholders while minimizing our environmental footprint.

Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the safe harbor for forward-looking statements provided by Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on these forward-looking statements, which are current only as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Important factors that could cause actual results to differ materially from those discussed or implied in the forward-looking statements include, but are not limited to: general economic or political conditions; negative economic conditions that could impact Blue Gold Limited and the gold industry in general; reduction in demand for Blue Gold Limited's products; changes in the markets that Blue Gold Limited targets; and any change in laws applicable to Blue Gold Limited or any regulatory or judicial interpretation.  As a result, we cannot assure you that the forward-looking statements included in this press release will prove to be accurate or correct. These and other important factors and risks are discussed in Blue Gold Limited’s shell company report on Form 20-F, filed with the U.S. Securities and Exchange Commission (the “SEC”) on July 1, 2025, and other filings with the SEC.  In light of these risks, uncertainties, and assumptions, the future performance or events described in the forward-looking statements in this press release might not occur. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results, and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. Except as required by applicable law, we do not undertake any obligation to, and will not, update any forward-looking statements, whether as a result of new information, future events, or otherwise. For more information regarding Blue Gold Limited, please visit https://bluegoldmine.com .

No Offer or Solicitation
This press release shall not constitute a solicitation of a proxy, consent, or authorization with respect to any securities or in respect of the proposed business combination. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption.

For Further Information Contact:
Tavistock Communications
[email protected]
+44 20 7920 3150

Skyline Corporate Communications Group, LLC
Scott Powell, President
Avenues Tower
1177 Avenue of the Americas, 5th floor
New York, NY 10036
Office: (646) 893-5835
Email: [email protected]

SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced a new initiative leveraging the expertise of its subsidiary IC’Alps to develop integrated cybersecurity and functional safety solutions for the global automotive industry.

This initiative aims to position SEALSQ at the forefront of protecting next-generation autonomous and connected vehicles against emerging cybersecurity threats. Autonomous and software-defined vehicles are becoming highly interconnected digital platforms, relying on over-the-air (OTA) updates, vehicle-to-everything (V2X) communication, and advanced sensor fusion capabilities. However, classical cryptographic systems, such as RSA and ECDSA, are vulnerable to future quantum computer attacks, which could compromise vehicle control systems, data integrity, navigation, and safety.

With autonomous vehicles becoming mission-critical systems, cybersecurity and functional safety must evolve together. SEALSQ plans to leverage its secure semiconductor technology in combination with the expertise of its subsidiary IC’Alps, a leader in custom ASIC design for safety-critical industries.

Because it is cheaper and always safer to prevent, rather than correct failure consequences, IC’Alps applies Failure Modes and Effects Analysis (FMEA) as a core methodology to detect, mitigate, and prevent potential systematic failures as early as possible. As ASICs frequently power critical system functions in automotive, IC’Alps integrates DFMEA (Design FMEA) into its design strategy in full compliance with IATF 16949 and other safety-sensitive industry standards such as medical devices (ISO 13485) and aeronautics (AS 9100 / JISQ 9100 / EN 9100). This proactive approach aims to ensure reliability, quality, and long-term operational integrity.

Additionally, these processes can directly support customers targeting ISO 26262 certification and developing systems across ASIL-A to ASIL-D levels. FMEA is a cornerstone of the technical risk management process under IATF 16949, ensuring robustness in design and production by anticipating and preventing failures that could affect yield, reliability, and safety. IC’Alps has developed and continued to develop critical IP blocks and complete ASICs for demanding automotive applications for worldwide leading semiconductor players, and Tier 1 suppliers , up to ASIL certification.

With IC’Alps’ expertise in DFMEA, ASIC development rigor, and activities dealing with ISO 21434 (automotive cybersecurity), SEALSQ ensures its secure silicon meets the highest standards of both cybersecurity resilience and functional safety for the automotive industry.
https://www.icalps.com/fr/how-fmea-tools-translates-to-automotive-asic-design-at-icalps/

Why Post-Quantum Security is Critical for Autonomous Vehicles

As vehicles evolve into fully connected, software-defined systems, cybersecurity is no longer optional, it is foundational to safety, reliability, and consumer trust. Post-quantum security represents the next frontier in protecting these intelligent platforms from emerging threats including:

• Imminent quantum vulnerability: Classical encryption protecting vehicles today will be breakable by quantum computers.
• Growing connectivity risks : Constant OTA and V2X interactions expand attack surfaces.
• Future-proofing safety and trust: Post-quantum cryptography (PQC) implementation ensures long-term vehicle integrity and secure autonomy.
  
  

"The future of mobility must be secure by design, not only for today, but for the quantum era," said Carlos Moreira, Founder & CEO of SEALSQ. "By combining SEALSQ’s post-quantum cybersecurity leadership with IC’Alps' world-class ASIC safety methodology, we aim to ensure autonomous vehicles remain protected, reliable, and trusted for decades ahead."

About SEALSQ:

SEALSQ is a leading innovator in Post-Quantum Technology hardware and software solutions. Our technology seamlessly integrates Semiconductors, PKI (Public Key Infrastructure), and Provisioning Services, with a strategic emphasis on developing state-of-the-art Quantum Resistant Cryptography and Semiconductors designed to address the urgent security challenges posed by quantum computing. As quantum computers advance, traditional cryptographic methods like RSA and Elliptic Curve Cryptography (ECC) are increasingly vulnerable.

SEALSQ is pioneering the development of Post-Quantum Semiconductors that provide robust, future-proof protection for sensitive data across a wide range of applications, including Multi-Factor Authentication tokens, Smart Energy, Medical and Healthcare Systems, Defense, IT Network Infrastructure, Automotive, and Industrial Automation and Control Systems. By embedding Post-Quantum Cryptography into our semiconductor solutions, SEALSQ ensures that organizations stay protected against quantum threats. Our products are engineered to safeguard critical systems, enhancing resilience and security across diverse industries.

For more information on our Post-Quantum Semiconductors and security solutions, please visit www.sealsq.com .

Forward-Looking Statements
This communication expressly or implicitly contains certain forward-looking statements concerning SEALSQ Corp and its businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, events or developments that we expect or anticipate will occur in the future, as well as any other statements which are not historical facts. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include SEALSQ's ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; and the risks discussed in SEALSQ's filings with the SEC. Risks and uncertainties are further described in reports filed by SEALSQ with the SEC.

SEALSQ Corp is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

MIAMI, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) ("Wrap" or the "Company") , a global leader in innovative non-lethal public safety technologies company, today announced that the Company’s BolaWrap® Instructor Course has been recertified through the International Association of Directors of Law Enforcement Standards and Training (IADLEST) National Certification Program (NCP).

Originally certified in 2023, this 2025 renewal indicates that Wrap’s core non-lethal training curriculum continues to meet the national standard for police and corrections education established by IADLEST and adopted by Peace Officer Standards and Training (POST) organizations across the country. National Certification is currently accepted in 37 states, with several states working on legislation to make NCP certification mandatory, positioning Wrap’s training content for broader adoption and agency-level credit eligibility.

The IADLEST National Certification Program, launched in 2015, was created to establish a single, rigorous national standard for law enforcement training. Courses submitted for NCP must meet strict criteria in content, instructor materials, and student support. All submissions are evaluated by a panel of law enforcement training experts to ensure that certified courses fulfill or surpass state POST requirements and can be credited for mandated continuing education. For agencies, this external validation helps lessen administrative workload and supports liability mitigation by demonstrating that officers were trained according to an accepted national standard.

Wrap’s 2025 recertification includes several significant upgrades to the BolaWrap® Instructor Course, supporting the Company’s non-lethal pre-escalation strategy and the expanded deployment of the BolaWrap® 150:

• Curriculum refocused on non-lethal criteria and hands-on control tactics founded in policy;
• Focus on “when” and “why” Best BolaWrap techniques and tactics, not just device operation;
• Redefined success metrics on compliance or control without resorting to higher levels of force, achieved through sight, sound, sensation, and, when needed, restraint;
• Refreshed field-use videos, scenarios, and analysis to reflect real-world applications.
  
  

The Company expects this recognized training credential to support Wrap’s 2026 training and engagement strategy under WrapTactics™ by making non-lethal instruction more accessible to operators, instructors, and allied public-safety professionals seeking to improve outcomes in their communities. As Wrap develops additional training modules, including those built in collaboration with other law enforcement training leaders, the Company plans to evaluate future courses for NCP submission to maintain a high-value, credible training portfolio.

Wrap’s public safety portfolio includes the non-lethal BolaWrap® 150 device, the WrapReality™ immersive training platform, WrapVision™ body-worn camera and evidence management system, WrapTactics™ training programs, and next-generation counter-UAS solutions, all designed to provide safer, scalable, and cost-effective technologies for public safety, defense, and critical infrastructure customers.

About Wrap Technologies, Inc.

Wrap Technologies, Inc. (Nasdaq: WRAP) a global leader in innovative public safety technologies and non-lethal tools, delivering cutting-edge technology with exceptional people to address the complex, modern day challenges facing public safety organizations.

Wrap's complete public safety portfolio includes the non-lethal BolaWrap 150 device, WrapReality™ immersive training platform, WrapVision™ body-worn camera system, WrapTactics™ training programs, and next-generation CUAS solutions like PAN-DA and the 1KC Kinetic Anti-Drone Cassette, all of which supports the Company's mission to provide safer, scalable, and cost-effective technologies for public safety, defense, and critical infrastructure markets. Wrap’s BolaWrap® 150 solution leads in pre-escalation intended to provide law enforcement with a safer choice for nearly every phase of a critical incident. This innovative, patented device deploys a multi-sensory, cognitive disruption that leverages sight, sound and sensation to expand the pre-escalation period and gives officers the advantage and critical time to manage non-compliant subjects before resorting to higher-force options. The BolaWrap 150 is not pain-based compliance. It does not shoot, strike, shock, or incapacitate, instead, it helps officers strategically operate pre-escalation on the force continuum, reducing the risk of injury to both officers and subjects. Used by over 1,000 agencies across the U.S. and in 60 countries, BolaWrap® is backed by training certified by the International Association of Directors of Law Enforcement Standards and Training (IADLEST), reinforcing Wrap’s commitment to public safety through cutting-edge technology and expert training.

Wrap Reality™ VR is a fully immersive training simulator to enhance decision-making under pressure.

As a comprehensive public safety training platform, it provides first responders with realistic, interactive scenarios that reflect the evolving challenges of modern law enforcement. By offering a growing library of real-world situations, Wrap Reality™ is intended to equip officers with the skills and confidence to navigate high-stakes encounters effectively, which we believe leads to safer outcomes for both responders and the communities they serve.

WrapVision is an all-new body-worn camera and evidence management system built for efficiency.

Designed for efficiency, security, and transparency to meet the rigorous demands of modern law enforcement, WrapVision captures, stores, and helps manage digital evidence, ensuring operational security, regulatory compliance, and enhanced video picture quality and field of view.

The WrapVision camera, powered by IONODES, boasts streamlined cloud integration and final North American assembly, with a critical made-in-America roadmap projected for early 2026. This track helps ensure data integrity and helps eliminate critical concerns over unauthorized access or foreign surveillance risks.

Trademark Information

Wrap, the Wrap logo, BolaWrap®, Wrap Reality™ and Wrap Training Academy are trademarks of Wrap Technologies, Inc., some of which are registered in the U.S. and abroad. All other trade names used herein are either trademarks or registered trademarks of the respective holders.

Cautionary Note on Forward-Looking Statements – Safe Harbor Statement

This release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “anticipate,” “should”, “believe”, “target”, “project”, “goals”, “estimate”, “potential”, “predict”, “may”, “will”, “could”, “intend”, and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Moreover, forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control and include, but are not limited to, statements relating to Wrap’s planned future products, technologies, integration, intended product designs and expected benefits therefrom, expected market opportunities and outcomes related to Wrap’s products to increase officer and public safety. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ability to maintain compliance with the Nasdaq Capital Market’s listing standards; the Company’s ability to successfully implement training programs for the use of its products; the Company’s ability to manufacture and produce products for its customers; the Company’s ability to develop sales for its products; the market acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company’s product solutions; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the impact resulting from geopolitical conflicts and any resulting sanctions; the ability to obtain export licenses for counties outside of the United States; the ability to obtain patents and defend intellectual property against competitors; the impact of competitive products and solutions; and the Company’s ability to maintain and enhance its brand, as well as other risk factors mentioned in the Company’s most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, and other Securities and Exchange Commission filings. These forward-looking statements are made as of the date of this release and were based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

Investor Relations Contact:

(800) 583-2652
[email protected]

AVA to distribute, assemble and service Tembo’s full range of electric utility vehicles across Kenya, Tanzania, and wider East Africa

AVA’s existing assembly partners include Toyota, Fuso, Hino, Volvo, Scania, Tata and Mahindra

Strategic partnership strengthens Tembo’s regional presence through local assembly, sales, installation, and service network, unlocking access to a 500-million-person market

Tembo to establish an office in Kenya and a mobile technical support network

Established in 1975, AVA is the only assembler in the region to have achieved IATF16949 Certification

LONDON, Oct. 31, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company") today announced that its subsidiary, Tembo e-LV (“Tembo”), has signed a binding definitive agreement with Associated Vehicle Assemblers Ltd. (“AVA”), East Africa’s largest and most experienced vehicle assembler, to distribute, assemble, and service Tembo’s 100% electric utility vehicles (“EUVs”) across Kenya, Tanzania, and other East African nations.

The agreement marks a significant milestone in Tembo’s global electrification rollout and underscores its strategy of building sustainable, regionally anchored partnerships. With AVA’s extensive experience assembling vehicles for leading OEMs—including Toyota, Fuso, Hino, Mahindra, Scania, Tata, Volvo, and Daewoo—the partnership establishes a robust local platform for deployment and long-term support of Tembo’s electric mobility and energy solutions.

Through this collaboration, Tembo and AVA will deliver on-the-ground assembly, installation, and maintenance services, ensuring customers across East Africa benefit from reliable local support. Tembo will also work closely with AVA to upskill local technicians and engineers, strengthening regional expertise in electric vehicle assembly, servicing, and energy integration.

As part of the partnership, Tembo will establish a local office and a mobile technical support network to enhance service delivery and operational readiness. The initiative is expected to foster local job creation, knowledge transfer, and supply-chain development, supporting Kenya’s and the region’s transition to sustainable mobility and green industrialisation.

Matt Lloyd, Managing Director of AVA, said: “We are excited to partner with Tembo at such a pivotal moment for Kenya’s transition to electric mobility. The country is taking a bold, forward-looking approach to EV adoption, and Tembo’s portfolio of products aligns perfectly with our vision. It was a pleasure hosting the Tembo team at our Mombasa facility, and with their continued support, we’re confident this partnership will deliver significant benefits for AVA, our customers, and the local economy.”

Kevin Chin, Executive Chairman of VivoPower, said: “We are proud to formalize this definitive partnership with AVA, an institution that has set the benchmark for quality and credibility in East Africa’s automotive industry. This binding agreement is part of our broader strategy to forge long-term alliances with trusted regional leaders who share our vision for electrification and energy transition. Together, Tembo and AVA will drive tangible decarbonisation across vital industries while supporting sustainable economic growth.”

Matthew Nestor, Director and Head of Global Partnerships at Tembo , said: “Signing this definitive agreement marks a pivotal step in Tembo’s mission to deliver reliable, rugged, and cost-effective electric mobility solutions for Africa. AVA’s deep manufacturing expertise and established OEM relationships, combined with Tembo’s proven engineering and safety standards, create a powerful platform to electrify commercial fleets across the region.”

About Tembo

Tembo electric utility vehicles (EUVs) are a 100% electric solution for ruggedised and/or customised applications for fleet owners in the mining, agriculture, energy utilities, defence, police, construction, infrastructure, government, humanitarian, and game safari industries. Tembo provides safe, high-performance off-road and on-road electric utility vehicles. Its core purpose is to provide safe and reliable electrification solutions for utility vehicle fleet owners, helping to perpetuate useful life, reduce costs, maximise return on assets, meet ESG goals and seeks to further the circular economy. Tembo is a subsidiary of VivoPower, a Nasdaq-listed B Corporation.

About VivoPower

VivoPower International PLC (NASDAQ: VVPR) is a sustainability-driven enterprise undergoing a digital treasury transformation. The Company’s new direction centers on the acquisition, management, and long-term holding of XRP digital assets as part of a diversified digital treasury strategy. Through this shift, VivoPower aims to contribute to the growth and utility of the XRP Ledger (XRPL) by supporting decentralized finance (DeFi) infrastructure and real-world blockchain applications.

Originally founded in 2014 and listed on Nasdaq since 2016, VivoPower operates with a global footprint spanning the United Kingdom, Australia, North America, Europe, the Middle East, and Southeast Asia. An award-winning global sustainable energy solutions B Corporation, VivoPower has two business units, Tembo and Caret Digital. Tembo is focused on electric solutions for off-road and on-road customized and ruggedized fleet applications, as well as ancillary financing, charging, battery, and microgrid solutions. Caret Digital is a power-to-x business focused on the highest and best use cases for renewable power, including digital asset mining.

About AVA

Associated Vehicle Assemblers Ltd. (AVA) is East Africa’s leading vehicle assembler, with decades of experience in producing high-quality vehicles tailored to meet the unique needs of the region. Based in Mombasa, AVA has established itself as a trusted partner for global automotive brands, providing state-of-the-art assembly services and technical expertise. AVA’s commitment to quality, innovation, and sustainability has made it a key player in Kenya’s automotive industry, driving economic growth and supporting the transition to more sustainable transport solutions. As a pioneer in the region, AVA continues to lead the way in assembling vehicles that meet the highest global standards while catering to local market demands.

Forward-Looking Statements

This communication includes certain statements that may constitute "forward-looking statements" for purposes of the U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about the achievement of performance hurdles, or the benefits of the events or transactions described in this communication and the expected returns therefrom. These statements are based on VivoPower's management's current expectations or beliefs and are subject to risk, uncertainty, and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive and/or regulatory factors, and other risks and uncertainties affecting the operation of VivoPower's business. These risks, uncertainties and contingencies include changes in business conditions, fluctuations in customer demand, changes in accounting interpretations, management of rapid growth, intensity of competition from other providers of products and services, changes in general economic conditions, geopolitical events and regulatory changes, and other factors set forth in VivoPower's filings with the United States Securities and Exchange Commission. The information set forth herein should be read in light of such risks. VivoPower is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements whether as a result of new information, future events, changes in assumptions or otherwise.

Source: Fuso

Contact
Shareholder Enquiries
[email protected]

LOUDON, Tenn., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (NYSE: MBUU), the global leader in watersports towboats, proudly announces that the iconic Malibu Wakesetter 23 LSV has once again been named Wakesurf and Wakeboard Boat of the Year by the WakeWorld Riders Choice Awards — marking an unprecedented sixth consecutive win for the world’s best-selling watersports boat.

“Having riders and families choose the 23 LSV as Boat of the Year for six straight seasons is the highest compliment we could receive,” said Rachael Green, Senior Vice President of Engineering and Operations at Malibu Boats. “It proves that the performance, versatility, and reliability we engineer into every Malibu are delivering what matters most — unforgettable days on the water with the people they love.”

Renowned for its iconic design, balanced performance, and legendary versatility, the 23 LSV delivers the ultimate combination of luxury, innovation, and wake-shaping power. With seating for up to 16 passengers and Malibu’s exclusive Wake Plus™ Hull or Diamond Hull™ options, the 23 LSV is engineered for every kind of day on the water — from family surf sessions to professional-level competitions. Technologies like Surf Gate®, Power Wedge III, and the Malibu Command Center™ allow riders to fine-tune their wakes and waves with the touch of a button, creating the most customizable experience in watersports.

Malibu Boats also celebrates its talented team riders who were recognized among the sport’s best in this year’s WakeWorld Riders Choice Awards. View the full list of winners here .

• Bec Gange (Axis) – 1st Place, Top Female Wakeboarder
• Brian Grubb (Malibu) – 1st Place, Top Wakeskater
• Guenther Oka (Axis) – 2nd Place, Top Male Wakeboarder
• Massi Piffaretti (Malibu) – 6th Place, Top Male Wakeboarder
• Hinata Yoshihara (Prospective Axis Team Rider) – 5th Place, Top Female Wakeboarder

“These awards reflect the relentless dedication and hard work of the athletes who represent Malibu and Axis around the world,” added Green. “We’re incredibly proud of them. Their commitment to excellence and their drive to push the sport forward embody the same values that guide everything we build.”

For more information about the Malibu Wakesetter 23 LSV, visit your local Malibu Boats dealer or build your custom configuration using Malibu’s interactive 3D Boat Builder at www.malibuboats.com .

About Malibu Boats, Inc.
Malibu Boats, Inc. (NYSE: MBUU) is a leading designer, manufacturer, and marketer of a diverse range of recreational powerboats, including performance sport, sterndrive, and outboard boats. Malibu Boats, Inc. is the market leader in the performance sport boat category through its Malibu and Axis boat brands, the leader in the 20’–40’ segment of the sterndrive boat category through its Cobalt brand, and in a leading position in the saltwater fishing boat market with its Pursuit and Cobia offshore boats and Pathfinder, Maverick, and Hewes flats and bay boat brands. A preeminent innovator in the powerboat industry, Malibu Boats, Inc. designs products that appeal to an expanding range of recreational boaters, fishermen, and watersports enthusiasts whose passion for boating is a key component of their active lifestyles.

For more information, visit www.malibuboats.com , www.axiswake.com , www.cobaltboats.com , www.pursuitboats.com , or www.maverickboatgroup.com .

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cb8f71f0-f97b-4076-a42f-b4d76cb77a19

FREMONT, Calif, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced that on October 28, 2025, the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has evidenced compliance with the stockholders’ equity requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1).

Nasdaq also notified the Company that the Nasdaq Hearings Panel (the “Panel”) granted the Company’s request for an extension to demonstrate compliance with the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(1), through December 5, 2025. The Company has scheduled a special meeting of shareholders on November 7, 2025, at which it will seek shareholder approval for the implementation of a reverse stock split to timely regain compliance with the bid price requirement.

“We are pleased to have received this update from Nasdaq confirming that we have regained compliance with Nasdaq’s equity standard,” said Tuvia Barlev, Chairman and CEO of Actelis Networks. “With momentum across key sectors - including government, defense, ITS, and MDUs, we remain confident in our ability to sustain compliance with Nasdaq’s equity requirement and to regain compliance with the Nasdaq bid price requirement in the near term, and are focused on delivering sustained value to our shareholders.”

Nasdaq also informed the Company that, assuming the Company regains compliance with the bid price requirement by December 5, 2025, the Company will remain subject to a Panel Monitor for a period of one year, through October 28, 2026. If, within that period, the Company fails to satisfy any of the criteria for continued listing on The Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550, Nasdaq will issue a delist determination, which the Company may address by requesting a new hearing before the Panel.

About Actelis Networks, Inc.

Actelis Networks, Inc. (NASDAQ: ASNS) is a market leader in hybrid fiber-copper, cyber-hardened networking solutions for rapid deployment in wide-area IoT applications, including government, ITS, military, utility, rail, telecom, and campus networks. Actelis' innovative portfolio offers fiber-grade performance with the flexibility and cost-efficiency of hybrid fiber-copper networks. Through its "Cyber Aware Networking" initiative, Actelis also provides AI-based cyber monitoring and protection for all edge devices, enhancing network security and resilience. For more information, please visit www.actelis.com .

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections, including but not limited to, our ability to regain and maintain compliance with continued listing requirements of the Nasdaq Capital Market. Actual results to differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Contact:
Arx Investor Relations
North American Equities Desk
[email protected]

Additional Bitcoin Acquisition Follows Immediately on $44 Million Equity Offering

Company now holds a total of 378 BTC (valued at ~$46 Million)

CHARLOTTE, N.C., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announces the acquisition of 100 Bitcoin, at an average price of $109,594 per Bitcoin. This acquisition demonstrates the Company's dedication and continued discipline to building its Bitcoin treasury.

Strategic Capital Deployment Following Successful Equity Raise

This Bitcoin acquisition represents the initial deployment of proceeds from Prenetics' recently completed $44 million equity offering, which closed on October 28, 2025. The significantly oversubscribed offering attracted high-quality strategic investors including Kraken, Exodus, GPTX by Jihan Wu (Founder and CEO of NASDAQ-listed Bitdeer), XtalPi, DL Holdings and World No. 1 tennis champion Aryna Sabalenka, validating the Company's innovative dual-engine strategy combining health innovation with digital asset treasury management.

"This 100 Bitcoin acquisition demonstrates our immediate execution on the strategic vision we outlined to investors," said Danny Yeung, Chief Executive Officer of Prenetics. "Given our successful capital raise, our balance sheet is now exceptionally strong with $127 million in total liquidity and zero debt, providing us with substantial runway to execute our growth strategy. With IM8 reaching $100 million in annual recurring revenue in just 11 months—the fastest growth in supplement industry history—our focus is now on accelerating growth for IM8 globally across new markets and product lines. Our dual-engine strategy positions this growth acceleration as our primary driver, while our Bitcoin treasury strategy provides additional long-term value creation. We now have all the capital we need to maintain IM8's market leadership while building substantial treasury assets for the future."

Balance Sheet & Liquidity

Following the Bitcoin acquisition and equity raise closing, Prenetics maintains a robust financial position with approximately $127 million in total liquidity ($86 million in cash and $41 million in Bitcoin holdings via 378 BTC). The Company continues its systematic Bitcoin accumulation strategy of 1 Bitcoin per day alongside strategic larger acquisitions during favorable market conditions. This strong balance sheet provides substantial runway for the Company's dual-engine growth strategy while maintaining zero debt.

IM8

The Company's IM8 supplement brand continues its record-breaking growth trajectory, having reached $100 million in annual recurring revenue within just 11 months of launch – the fastest growth ever recorded in the global supplements industry. With 420,000 customers and 80% of new orders being subscriptions, IM8 provides a strong cash-generating foundation supporting the Company's Bitcoin accumulation strategy.

The Company recently released FY2026 Revenue guidance for IM8, expecting revenues of $180 to $200 million.

CEO’s Strategic Vision and Manifesto

The recently released CEO's comprehensive manifesto, detailing the Company's ambitious vision, is available at www.prenetics.com/manifesto . The manifesto articulates Yeung's conviction that traditional corporate treasury strategies are obsolete in an era of currency debasement and digital transformation. It outlines how Prenetics is pioneering the world's first "health-and-wealth" platform, combining explosive growth in the $700+ billion wellness market with strategic Bitcoin accumulation. The document has garnered significant attention from investors and industry leaders for its bold vision of creating unprecedented shareholder value through this innovative dual-engine approach.

For real-time access to the Company’s Bitcoin holdings, please visit https://prenetics.com/btc

About Prenetics

Prenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8 — its flagship consumer brand co-founded with David Beckham and championed by World No. 1 and four-time Grand Slam winner Aryna Sabalenka — now the fastest-growing supplement brand globally, reaching $100 million in annual recurring revenue within just 11 months of launch — the fastest growth ever recorded in the global history of the supplements industry, even outpacing today’s leading AI startups.

As the first consumer health company to establish a Bitcoin Treasury, Prenetics continues to pioneer at the intersection of health innovation and digital assets — purchasing 1 Bitcoin per day, now totaling 378 BTC as of October 31, 2025.

Investor Relations Contact:

[email protected]
[email protected]

Angela Cheung
Investor Relations / Corporate Finance
[email protected]

WEST HOLLYWOOD, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- VisionWave Holdings Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”), a defense-technology company advancing AI-powered sensing and autonomy across air, land, and maritime domains, today announced that Zacks Small-Cap Research has published an independent research note initiating coverage on VisionWave. The report, authored by analyst Tom Kerr and titled “VWAV: VisionWave Redefines the Future of Defense — Transitioning from R&D to Commercialization with Breakthrough Autonomous and Sensing Technologies” .

The coverage — now syndicated on Yahoo Finance, LinkedIn, Stocktwits, and X (formerly Twitter) — highlights VisionWave’s progress from a development-stage platform to a commercially validated defense-AI enterprise. Zacks identified VisionWave’s core technologies — the Evolved Intelligence™ autonomous AI engine and the Vision-RF radio-frequency imaging system — as “game-changing capabilities that redefine how modern militaries perceive, decide, and act across land, air, and sea.”

The report underscored VisionWave’s active pilots with Tier-1 defense contractors and government partners in the United States, United Arab Emirates, Israel, and India and concluded that the Company is entering a “steep inflection point as it transitions from pilot deployments to scalable defense production.”

“Independent coverage from Zacks adds another layer of validation to VisionWave’s story,” said Doug Davis , Executive Chairman of VisionWave Holdings Inc. “It follows our S&P Total Market Index inclusion, Nasdaq Dorsey Wright 5/5 technical rating, and recent approximate $4.6 million in warrant exercises — all of which are objective signals that institutional interest and market recognition are accelerating. We view this as a clear reflection of confidence in our technology and our execution roadmap heading into 2026.”

Full Zacks coverage is available at: https://scr.zacks.com/news/news-details/2025/VWAV-VisionWave-Redefines-the-Future-of-Defense-Transitioning-from-RD-to-Commercialization-with-Breakthrough-Autonomous-and-Sensing-Technologies-with-Strong-Revenue-Growth-Expected-in-2026-and-Beyond-/default.aspx

About VisionWave Holdings Inc.

VisionWave (Nasdaq: VWAV) is a defense-technology company specializing in AI-powered sensing, on-edge autonomy, and threat-response systems. Its Evolved Intelligence™ engine and Vision-RF sensing platform enable real-time perception, prediction, and control for military and security applications across air, land, and sea domains. VisionWave is headquartered in West Hollywood, California, with operations in the United States, Israel, and the UAE. For more information, visit www.vwav.inc .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to statements regarding Zacks Small-Cap Research's views on the Company’s projected expected revenue growth, commercial transition, inflection point, strategic initiatives, and market position as described in the Zacks report. These statements are based on current expectations of Zacks Small-Cap Research and are subject to risks and uncertainties that could cause actual results to differ materially, including but not limited to: (i) failure to successfully convert pilot programs into commercial production contracts; (ii) delays or issues in scaling production; (iii) competitive pressures in the defense-AI sector; (iv) dependence on key partnerships with Tier-1 contractors and government entities; (v) regulatory, execution, and funding risks (including potential dilution); and (vi) other risks detailed in the Zacks report and in Readers are cautioned not to place undue reliance on these forward-looking statements. For further information on risk factors, please refer to VisionWave’s filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update these statements after the date of this release.

Investor Contact: [email protected]

Website: https://www.vwav.inc

MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the presentation of two abstracts at ObesityWeek 2025 taking place November 4-7, 2025, in Atlanta, Georgia.

Poster presentation name: Enobosarm Reduced Body Weight and Fat Regain and Preserved Lean Mass After Discontinuing Semaglutide
Presenter: Steven B. Heymsfield, M.D., a Professor and the Director of the Body Composition-Metabolism Laboratory at the Pennington Biomedical Research Center in Baton Rouge, Louisiana
Session Date: Tuesday, November 4, 2025
Session Time: 7:30 pm - 8:30 pm Eastern Time
Session Room: Exhibit Hall A1

Oral presentation name: Enobosarm in Combination With GLP-1RA is Selective for Fat Loss While Preserving Lean and Function
Presenter: Mitchell Steiner, M.D., Chairman, President, and Chief Executive Officer of Veru
Session Date: Friday, November 7, 2025
Session Time: 8:00 am - 8:15 am Eastern Time
Session Room: GWCC Building A: A411-A412

Additional information on the meeting can be found on the following website: https://obesityweek.org/ .

About Veru Inc.
Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases. The Company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin. Enobosarm, a selective androgen receptor modulator (SARM), is being developed as a next generation drug that makes weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass thereby improving body composition and physical function with expected clinically meaningful incremental weight reduction versus GLP-1 RA monotherapy. Sabizabulin, a microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease.

Enobosarm Obesity Program - Enobosarm is a next generation drug that makes weight reduction by GLP-1 RA more tissue selective for fat loss – Phase 2b QUALITY clinical study
The Phase 2b QUALITY clinical study was a positive multicenter, double-blind, placebo-controlled, randomized, dose-finding clinical trial designed to evaluate the safety and efficacy of enobosarm 3mg, enobosarm 6mg, or placebo as a treatment to augment fat loss and to prevent muscle loss in 168 older patients (≥60 years of age) receiving semaglutide (Wegovy ^® ) for weight reduction. After completing the efficacy dose-finding portion of the Phase 2b QUALITY clinical trial ended at 16 weeks, participants continued into a Phase 2b maintenance extension study where all patients discontinued semaglutide treatment, but continued receiving placebo, enobosarm 3mg, or enobosarm 6mg as monotherapy in a double-blind fashion for 12 weeks. The Phase 2b QUALITY and Maintenance Extension clinical trial was a positive study that demonstrated that preserving lean mass and physical function with enobosarm plus semaglutide led to greater fat loss during the 16 week active weight loss period. While weight loss was similar across treatment groups in this short 16 week study, it is expected that preservation of lean mass and function will increase energy expenditure coupled with the direct effects of enobosarm on the additional selective reduction in fat mass will result in incremental weight reduction in a longer clinical study in patients who have obesity.

Planned Phase 2b PLATEAU clinical study
Veru’s planned Phase 2b PLATEAU clinical study will evaluate the effect of enobosarm 3mg on total body weight, physical function, and safety in approximately 200 older (≥65 yo) and younger (<65 yo) patients who have obesity and are initiating GLP-1 RA treatment for weight reduction. The primary efficacy endpoint of the study is the percent change from baseline in total body weight at 72 weeks. An interim analysis will be conducted at 36 weeks to assess the percent change from baseline in lean body mass and fat mass, as measured by DEXA. The key secondary endpoints are total fat mass, total lean mass, physical function (stair climb test), bone mineral density, and patient reported outcome questionnaires for physical function (SF-36 PF-10, and IWQOL-lite CT physical function).
The Phase 2b PLATEAU clinical study is designed to assess the ability of enobosarm treatment to break through the weight loss plateau observed in patients with obesity receiving GLP-1 RA treatment to achieve clinically meaningful incremental weight reduction and preserve muscle mass and physical function by 72 weeks. The clinical study is expected to begin in calendar Q1 2026.

Forward-Looking Statements
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, express or implied statements related to the planned design, enrollment, timing, commencement, interim and full data readout timing, scope and regulatory pathways for the continued development of enobosarm in patients with obesity, including the planned PLATEAU Phase 2b study; whether clinically meaningful incremental weight loss in the PLATEAU Phase 2b study will continue to be seen as an acceptable primary endpoint by the FDA to support potential approval; whether the FDA will continue to accept 3mg as an acceptable dosage for enobosarm in the planned PLATEAU Phase 2b study or in any other studies; whether the FDA will further evolve its position on the acceptable patient population for the PLATEAU Phase 2b study or any other future studies; whether the Company will be able to partner with any other company in the development of enobosarm; whether the results of the Phase 2b QUALITY study and the extension maintenance study of enobosarm will be replicated to the same or any degree in the planned PLATEAU Phase 2b study or in any future Phase 3 studies; the expected costs, timing, patient population, design, endpoints and results of the planned PLATEAU Phase 2b study or any future Phase 3 studies of enobosarm in patients with obesity; whether the Company will be able to raise sufficient capital, dilutive or otherwise, to fund the PLATEAU Phase 2b study of enobosarm in patients with obesity or any other studies; whether the Company will be able to recruit a sufficient number of patients in a timely manner for the PLATEAU Phase 2b study; whether the modified-released formulation of enobosarm will be developed successfully and whether such formulation will have the same effectiveness or bioequivalence as the current formulation, and whether and when such modified-release formulation will be available for any planned or future clinical studies; whether and when any patents will actually issue regarding such modified-release formulation and what any expiration dates of any such patents might be; whether the Company will be able to obtain sufficient GLP-1 RA drugs in a timely or cost-effective manner in the planned PLATEAU Phase 2b study or any future Phase 3 studies; whether the Company will be able to engage clinical research organizations and recruit patients for the PLATEAU Phase 2b program and in a timely or cost-effective manner; whether enobosarm will cause weight loss or preserve muscle in, or meet any unmet need for, obesity patients and whether it will cause weight loss in the planned PLATEAU Phase 2b study or any future Phase 3 studies or, if approved and commercialized, in clinical practice; whether patients treated with enobosarm for a longer period of time than in the Phase 2b QUALITY study will experience weight loss or have a greater loss of adiposity or greater weight loss than with GLP-1 RA drug alone; whether and when enobosarm will be approved by the FDA as a weight loss drug or a body composition drug or any other type of drug; and whether and when the Company will be able to further advance the development of sabizabulin in atherosclerotic disease. The words "anticipate," "believe," "could," "expect," "intend," "may," "opportunity," "plan," "predict," "potential," "estimate," "should," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based upon current plans and strategies of the Company and reflect the Company's current assessment of the risks and uncertainties related to its business and are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statements contained in this press release because of new information or future events, developments, or circumstances. Such forward-looking statements are subject to known and unknown risks, uncertainties and assumptions, and if any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our actual results could differ materially from those expressed or implied by such statements. Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include, but are not limited to: the development of the Company’s product portfolio and the results of clinical studies possibly being unsuccessful or insufficient to meet applicable regulatory standards or warrant continued development; the Company’s ability to reach agreement with FDA on study design requirements for the Company’s planned clinical studies, including for the Phase 2b program for enobosarm as a weight loss or body composition drug and the number of future Phase 3 studies to be required and the cost thereof; potential delays in the timing of and results from clinical trials and studies, including as a result of an inability to enroll sufficient numbers of subjects in clinical studies or an inability to enroll subjects in accordance with planned schedules; the ability to fund planned clinical development as well as other operations of the Company; the timing of any submission to the FDA or any other regulatory authority and any determinations made by the FDA or any other regulatory authority; the potential for disruptions at the FDA or other government agencies to negatively affect our business; any products of the Company, if approved, possibly not being commercially successful; the ability of the Company to obtain sufficient financing, including any partnership or collaboration agreements, on acceptable terms when needed to fund development and operations; demand for, market acceptance of, and competition against any of the Company’s products or product candidates; new or existing competitors with greater resources and capabilities and new competitive product approvals and/or introductions; changes in regulatory practices or policies or government-driven healthcare reform efforts, including pricing pressures and insurance coverage and reimbursement changes; the Company’s ability to protect and enforce its intellectual property; costs and other effects of litigation, including regulatory challenges, product liability claims, intellectual property and securities litigation; the Company’s ability to identify, successfully negotiate and complete suitable acquisitions or other strategic initiatives; the Company’s ability to successfully integrate acquired businesses, technologies or products; and other risks detailed from time to time in the Company’s press releases, shareholder communications and Securities and Exchange Commission filings, including the Company's Form 10-K for the year ended September 30, 2024, and subsequent quarterly reports on Form 10-Q. These documents are available on the “SEC Filings” section of our website at www.verupharma.com/investors .
Wegovy® is a registered trademark of Novo Nordisk A/S.

Investor and Media Contact:
Samuel Fisch
Executive Director, Investor Relations and Corporate Communications
Email: [email protected]

BEIJING, Oct. 31, 2025 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a pop toy company dedicated to creating beloved collectibles and trend-defining experiences, today announced that it filed its annual report on Form 20-F for the fiscal year ended June 30, 2025, with the Securities and Exchange Commission on October 31, 2025. The annual report on Form 20-F can be accessed on the SEC's website at http://www.sec.gov and on the Company's investor relations website at https://ir.quantasing.com/financials-filings/sec-filings .

The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s Investor Relations Department at [email protected] .

About the Company

The Company, through its Here (奇梦岛) brand, creates collectible pop toys that spark joy and inspire global culture. With innovative design and storytelling at its core, the Company delivers immersive experiences that connect deeply with collectors worldwide. Guided by joy, integrity, wonder, and co-creation, the Company is building vibrant cultural ecosystems where fans shape and share dreams.

For more information, please visit: https://ir.quantasing.com .

Contact

Investor Relations
Leah Guo
QuantaSing Group Limited
Email: [email protected]
Tel: +86 (10) 6493-7857

Robin Yang, Partner
ICR, LLC
Email: [email protected]
Phone: +1 (212) 537-0429

BANGKOK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced it has entered a binding term sheet with White Lion Capital LLC (“White Lion”) setting out the principal terms and conditions for a Digital Assets Purchase Agreement (the “Agreement”) with a commitment amount of 600,000 Solana (SOL) tokens.

Pursuant to the Term Sheet, NewGen will have the option, but not the obligation, to sell to White Lion shares of common stock of the Company over an initial 24-month period up to a total amount equivalent to the value of 600,000 Solana tokens. Upon a sale of shares, the Company will be compensated by White Lion in Solana tokens rather than cash. This innovative structure is designed to further the Company’s previously announced Solana treasury strategy, and reaffirms NewGen’s commitment to both the digital assets space as a whole and to Solana as a digital asset specifically.

The transactions contemplated by the Term Sheet are subject to entry into definitive agreements, and are subject to certain conditions, including a registration statement being filed immediately upon execution of the definitive agreements.

Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen commented, “This groundbreaking agreement with White Lion represents another key development in NewGen's evolution as a forward-thinking, diversified enterprise. By structuring this innovative arrangement to receive Solana tokens rather than traditional cash compensation, we are not only strengthening our digital asset treasury but also demonstrating our unwavering confidence in the future of blockchain technology and decentralized finance. We believe Solana's robust ecosystem and scalable infrastructure make it an ideal cornerstone for our digital asset strategy, positioning NewGen to capitalize on the tremendous growth opportunities at the intersection of traditional industries and the digital economy.”

Nathan Yee, Managing Partner of White Lion, commented, “We believe this is more than just an investment, it’s a blueprint for the next era of capital formation. By exchanging shares for Solana tokens, we’re witnessing the convergence of blockchain and public markets.”

NewGen launched its digital asset strategy in December 2024, with an initial US$1 million investment to establish a digital asset portfolio. Since then, the Company has embraced digital assets as a core business line, establishing its Solana treasury in June 2025 and advancing innovative real-world asset (RWA) tokenization projects involving real estate and fine art. As of the date of this press release, NewGen has accumulated 13,000 Solana tokens with a total value of approximately US$2.5 million.

About NewGen
NewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates through three strategic business divisions that leverage cutting-edge technology and innovative solutions to drive sustainable growth and high ROI for shareholders across multiple global markets. These include “NewGenProperty”, which operates lucrative real estate development projects in the UAE’s Ras Al Khaimah Emirate; “NewGenDigital”, which serves as the Company’s digital assets and DeFi solutions arm; and “NewGenSup”, which focuses on health and longevity products and solutions. NewGen’s legacy business involves providing industry-leading IVF and assisted reproductive treatment services across Asia. With operations spanning multiple jurisdictions and a commitment to innovative, technology-enabled solutions, NewGenIVF Group is uniquely positioned to capitalize on the convergence of real estate, healthcare, and digital asset opportunities in the evolving global economy.

To learn more, visit www.newgenivf.com . The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and you should not consider it a part of this press release.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include but are not limited to: the potential value and benefits of the proposed Digital Assets Purchase Agreement; the Company's ability to further its Solana treasury strategy and strengthen its digital asset holdings; the Company's confidence in Solana and blockchain technology; and the potential for growth at the intersection of traditional industries and the digital economy. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company's ability to enter into a definitive Digital Assets Purchase Agreement with White Lion on acceptable terms, or at all; the risk that the registration statement required to be filed with the SEC may not become effective or may be delayed; the extreme volatility in the market price of Solana (SOL) and other digital assets, which could significantly impact the value of any potential capital received by the Company and the value of its existing digital asset treasury; the Company's decision on whether to exercise its option to sell shares, which it is not obligated to do; risks associated with the development, integrity, and maintenance of the Solana blockchain and its broader ecosystem, including potential technical vulnerabilities, security breaches, or network congestion; regulatory risks and uncertainties surrounding digital assets, securities laws, and the treatment of such transactions by regulatory bodies in the jurisdictions where the Company operates; and the Company's inability to fully implement its broader digital asset strategy or realize the anticipated benefits from its initiatives in the blockchain and digital assets space.

You should carefully consider the foregoing factors and the other risks and uncertainties described in NewGenIvf Group's Annual Report on Form 20-F and other documents filed or to be filed by NewGenIvf Group with the U.S. Securities and Exchange Commission (the "SEC") from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC's website, www.sec.gov . All information provided herein is as of the date of this press release, and the Company and NewGenIvf Group undertake no obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: [email protected]

NEW YORK and TOKYO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”) , an IPO consulting services company based in Tokyo, announced today it has sold its subsidiary HeartCore Co. Ltd. (“HeartCore Japan”) to Volaris Group UK Holdco LTD (“Volaris Group”) in an all-cash deal for approximately ¥1.8 billion yen (equivalent to approximately USD $12 million, based on the October 24, 2025 Federal Reserve conversion rate of ¥152.82 = USD $1). HeartCore Japan is engaged in the business of developing and sales of comprehensive software.

“The rapid evolution of generative AI has fundamentally reshaped the competitive landscape for traditional software businesses like ours,” said HeartCore CEO Sumitaka Kanno. “Generative AI agents are now capable of matching and even outperforming many conventional software offerings and businesses. With this apparent change in the industry, we have spent the past several months carefully evaluating the best path forward to continue delivering value to our shareholders. Rather than expending resources to compete against this industry-wide shift, HeartCore’s management and board have made the strategic decision to sell our software business assets in Japan at what we believe to be the highest achievable value at this stage and to concentrate our efforts on our robust Go IPO consulting business.

“While this transaction does not include our subsidiary Sigmaways, we will continue to assess all strategic alternatives to divest this portion of the business as soon as possible. We believe that the planned exit from all software business activities will allow us to focus exclusively on our highly profitable Go IPO business, transitioning from a software and consulting business model to a financial consulting firm. While the divestiture of our software business will reduce near-term revenue, our Go IPO pipeline remains strong. Looking ahead to 2026, we have multiple Go IPO clients scheduled to begin trading, and we believe the highly profitable nature of this business will enable us to drive sustainable, long-term value for our shareholders.”

Use of Proceeds – Distribution to Shareholders
As previously announced , the Company has authorized a one-time distribution payment to its shareholders in the amount of $0.13 per share of common stock. We expect to use a portion of the proceeds from the HeartCore Japan sale to pay the distribution. The record date for holders of the common stock to participate in the distribution is November 10, 2025, and the payment date will be November 17, 2025. The one-time distribution payment of $0.13 per share represents approximately 17.2% of the Company’s stock price as of market close on October 29, 2025.

Go IPO Business Tailwinds
HeartCore CEO Sumitaka Kanno continued: “Recently, the Tokyo Stock Exchange raised the minimum market capitalization requirement for Growth Market companies from ¥4 billion yen after 10 years to ¥10 billion yen after just 5 years. We believe this creates a powerful tailwind for our Go IPO business, as this accelerated timeline will pressure many companies to assess and seek alternative strategies that offer deeper liquidity, greater visibility, and higher valuations such as the Nasdaq and NYSE. Capturing even a small portion of this opportunity has the potential to bring significant long-term value to our growth trajectory.

“In the near term, we will continue to execute our organic growth strategy across Japan and Korea. After a successful Go IPO panel in Seoul last month, we are making significant strides in building out a pipeline with Korean companies that can benefit from our services. We remain committed to growing our Go IPO business to maximize value for our shareholders.”

About HeartCore Enterprises, Inc.
HeartCore is a Tokyo-based IPO consulting services company, guiding Japanese growth companies to achieve successful U.S. exchange listings through its flagship service, Go IPO. HeartCore’s Go IPO ^SM consulting services provide comprehensive consultation support, including pre-IPO consulting, regulatory guidance, financial preparation, and operational readiness to help businesses navigate the complexities of a successful U.S. listing. HeartCore’s goal is to streamline the entire process for Japanese companies to provide a seamless transition into the U.S. public markets. For more details, visit https://heartcore-enterprises.com/ .

Forward-Looking Statements
All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

HeartCore Investor Relations Contact:
Gateway Group, Inc.
John Yi and Steven Shinmachi
[email protected]
(949) 574-3860

PHOENIX, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).

The dividend will be payable on November 26, 2025, to holders of record at the close of business on November 12, 2025.

About Global Water Resources

Global Water Resources, Inc. is a leading water resource management company that owns and operates 39 systems which provide water, wastewater, and recycled water service. The company’s service areas are located primarily in growth corridors around metropolitan Phoenix and Tucson. Global Water recycles over 1 billion gallons of water annually with 18.5 billion gallons recycled since 2004.

The company has been recognized for its highly effective implementation of Total Water Management (TWM). TWM is an integrated approach to managing the entire water cycle that involves owning and operating water, wastewater and recycled water utilities within the same geographic area in order to maximize the beneficial use of recycled water. It enables smart water management programs such as remote metering infrastructure and other advanced technologies, rate designs, and incentives that result in real conservation. TWM helps protect water supplies in water-scarce areas experiencing population growth.

Global Water has received numerous industry awards, including national recognition as a ‘Utility of the Future Today’ for its superior water reuse practices by a national consortium of water and conservation organizations led by the Water Environment Federation (WEF). The company also received Cityworks’ Excellence in Departmental Practice Award for demonstrating leadership and creativity in applying public asset management strategies to daily operations and long-term planning.

To learn more, visit www.gwresources.com .

Company Contact:
Michael Liebman
CFO and SVP
Tel (480) 999-5104
Email Contact

Investor Relations Contact:
Ron Both or Grant Stude
Encore Investor Relations
Tel (949) 432-7450
Email Contact